نتائج البحث - "A. V. Pizov"

Relation: https://www.med-sovet.pro/jour/article/view/8208/7228; Чутко ЛС, Сурушкина СЮ. Астенические расстройства. История и современность. Журнал неврологии и психиатрии им. С.С. Корсакова. 2020;120(6): 131–136. https://doi.org/10.17116/jnevro2020120061131.; Визило ТЛ. Эффективность и безопасность препарата Актитропил в терапии реактивной астении у пациентов молодого возраста. Фарматека. 2023;30(9- 10):148–155. https://doi.org/10.18565/pharmateca.2023.9-10.159-166.; Vaes AW, Goërtz YMJ, van Herck M, Beijers RJHCG, van Beers M, Burtin C et al. Physical and mental fatigue in people with non-communicable chronic diseases. Ann Med. 2022;54(1):2522–2534. https://doi.org/10.1080/07853890.2022.2122553.; Karshikoff B, Sundelin T, Lasselin J. Role of inflammation in human fatigue: relevance of multidimensional assessments and potential neuronal mechanisms. Front Immunol. 2017:8:21. https://doi.org/10.3389/fimmu.2017.00021.; Wong TL, Weitzer DJ. Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)-A Systemic Review and Comparison of Clinical Presentation and Symptomatology. Medicina (Kaunas). 2021;57(5):418. https://doi.org/10.3390/medicina57050418.; Toogood PL, Clauw DJ, Phadke S, Hoffman D. Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): Where will the drugs come from? Pharmacol Res. 2021;165:105465. https://doi.org/10.1016/j.phrs.2021.105465.; Menting J, Tack CJ, Bleijenberg G, Donders R, Droogleever Fortuyn HA, Fransen J et al. Is fatigue a disease-specific or generic symptom in chronic medical conditions? Health Psychol. 2018;37(6):530–543. https://doi.org/10.1037/hea0000598.; Goërtz YMJ, Braamse AMJ, Spruit MA, Janssen DJA, Ebadi Z, Van Herck M et al. Fatigue in patients with chronic disease: results from the population-based lifelines cohort study. Sci Rep. 2021;11(1):20977. https://doi.org/10.1038/s41598-021-00337-z.; Goërtz YMJ, Spruit MA, Van’t Hul AJ, Peters JB, Van Herck M, Nakken N et al. Fatigue is highly prevalent in patients with COPD and correlates poorly with the degree of airflow limitation. Ther Adv Respir Dis. 2019;13:1753466619878128. https://doi.org/10.1177/1753466619878128.; Bloem AEM, Mostard RLM, Stoot N, Vercoulen JH, Peters JB, Janssen DJA et al. Severe fatigue is highly prevalent in patients with IPF or sarcoidosis. J Clin Med. 2020;9(4):1178. https://doi.org/10.3390/jcm9041178.; Finsterer J, Mahjoub SZ. Fatigue in healthy and diseased individuals. Am J Hosp Palliat Care. 2014;31(5):562–575. https://doi.org/10.1177/1049909113494748.; Kluger BM, Krupp LB, Enoka RM. Fatigue and fatigability in neurologic illnesses: proposal for a unified taxonomy. Neurology. 2013;80(4):409–146. https://doi.org/10.1212/WNL.0b013e31827f07be.; Hofman M, Ryan JL, Figueroa-Moseley CD, Jean-Pierre P, Morrow GR. Cancerrelated fatigue: the scale of the problem. Oncologist. 2007;12(Suppl 1):4–10. https://doi.org/10.1634/theoncologist.12-S1-4.; Chaudhuri A, Behan PO. Fatigue in neurological disorders. Lancet. 2004;363(9413):978–988. https://doi.org/10.1016/S0140-6736(04)15794-2.; Mollayeva T, Kendzerska T, Mollayeva S, Shapiro CM, Colantonio A, Cassidy JD. A systematic review of fatigue in patients with traumatic brain injury: the course, predictors and consequences. Neurosci Biobehav Rev. 2014;47:684–716. https://doi.org/10.1016/j.neubiorev.2014.10.024.; Zielinski MR, Systrom DM, Rose NR. Fatigue, Sleep, and Autoimmune and Related Disorders. Front Immunol. 2019;10:1827. https://doi.org/10.3389/fimmu.2019.01827.; Aaronson LS, Pallikkathayil L, Crighton F. A qualitative investigation of fatigue among healthy working adults. West J Nurs Res. 2003;25(4):419–433. https://doi.org/10.1177/0193945903025004007.; Waterhouse J, Reilly T, Atkinson G, Edwards B. Jet lag: trends and coping strategies. Lancet. 2007;369(9567):1117–1129. https://doi.org/10.1016/S0140-6736(07)60529-7.; Kunasegaran K, Ismail AMH, Ramasamy S, Gnanou JV, Caszo BA, Chen PL. Understanding mental fatigue and its detection: a comparative analysis of assessments and tools. Peer J. 2023;11:e15744. https://doi.org/10.7717/peerj.15744.; Craik FIM. Effects of distraction on memory and cognition: a commentary. Front Psychol. 2014;(5):841. https://doi.org/10.3389/fpsyg.2014.00841.; Tanaka M, Ishii A, Watanabe Y. Neural effects of mental fatigue caused by continuous attention load: a magnetoencephalography study. Brain Res. 2014;1561:60–66. https://doi.org/10.1016/j.brainres.2014.03.009.; Bong CL, Fraser K, Oriot D. Cognitive load and stress in simulation. Cham: Springer; 2016, pp. 3–17. Available at: https://link.springer.com/chapter/10.1007/978-3-319-24187-6_1.; Forster S, Lavie N. High perceptual load makes everybody equal. Psychol Sci. 2007;18(5):377–381. https://doi.org/10.1111/j.1467-9280.2007.01908.x.; Hu X, Lodewijks G. Detecting fatigue in car drivers and aircraft pilots by using non-invasive measures: the value of differentiation of sleepiness and mental fatigue. J Safety Res. 2020;72(2):173–187. https://doi.org/10.1016/j.jsr.2019.12.015.; Diamond A. Executive functions. Annu Rev Psychol. 2013;64(1):135–168. https://doi.org/10.1146/annurev-psych-113011-143750.; Nealley MA, Gawron VJ. The effect of fatigue on air traffic controllers. Int J Aviation Psychol. 2015;25(1):14–47. https://doi.org/10.1080/10508414.2015.981488.; Habibi E, Poorabdian S, Shakerian M. Job strain (demands and control model) as a predictor of cardiovascular risk factors among petrochemical personnel. J Educ Health Promot. 2015;4(1):16. https://doi.org/10.4103/2277-9531.154034.; Perrier J, Jongen S, Vuurman E, Bocca ML, Ramaekers JG, Vermeeren A. Driving performance and EEG fluctuations during on-the-road driving following sleep deprivation. Biol Psychol. 2016;121(Pt A):1–11. https://doi.org/10.1016/j.biopsycho.2016.09.010.; Tran Y, Craig A, Craig R, Chai R, Nguyen H. The influence of mental fatigue on brain activity: evidence from a systematic review with meta-analyses. Psychophysiology. 2020;57(5):e13554. https://doi.org/10.1111/psyp.13554.; Ekstedt M, Söderström M, Аkerstedt T, Nilsson J, Søndergaard HP, Aleksander P. Disturbed sleep and fatigue in occupational burnout. Scand J Work Environ Health. 2006;32(2):121–131. https://doi.org/10.5271/sjweh.987.; Ahola K, Hakanen J, Perhoniemi R, Mutanen P. Relationship between burnout and depressive symptoms: a study using the person-centred approach. Burnout Research. 2014;1(1):29–37. https://doi.org/10.1016/j.burn.2014.03.003.; Akerstedt T, Knutsson A, Westerholm P, Theorell T, Alfredsson L, Kecklund G. Mental fatigue, work and sleep. J Psychosom Res. 2004;57(5):427–433. https://doi.org/10.1016/j.jpsychores.2003.12.001.; Grillon C, Quispe-Escudero D, Mathur A, Ernst M. Mental fatigue impairs emotion regulation. Emotion. 2015;15(3):383–389. https://doi.org/10.1037/emo0000058.; Lorist MM, Klein M, Nieuwenhuis S, de Jong R, Mulder G, Meijman TF. Mental fatigue and task control: planning and preparation. Psychophysiology. 2000;37(5):614–625. Available at: https://pubmed.ncbi.nlm.nih.gov/11037038.; Helton WS, Russell PN. Rest is still best. Hum Factors. 2017;59(1):91–100. https://doi.org/10.1177/0018720816683509.; Warm JS, Matthews G, Parasuraman R. Cerebral hemodynamics and vigilance performance. Military Psychology. 2009;21:S75–S100. https://doi.org/10.1080/08995600802554706.; Shaw TH, Warm JS, Finomore V, Tripp L, Matthews G, Weiler E, Parasuraman R. Effects of sensory modality on cerebral blood flow velocity during vigilance. Neurosci Lett. 2009;461(3):207–211. https://doi.org/10.1016/j.neulet.2009.06.008.; Boksem MAS, Tops M. Mental fatigue: сost and benefits. Brain Res Rev. 2008;59(1):125–139. https://doi.org/10.1016/j.brainresrev.2008.07.001.; Earle F, Hockey B, Earle K, Clough P. Separating the effects of task load and task motivation on the effort-fatigue relationship. Motivation and Emotion. 2015;39(4):467–476. https://doi.org/10.1007/s11031-015-9481-2.; Jaime-Lara RB, Koons BC, Matura LA, Hodgson NA, Riegel B. A qualitative metasynthesis of the experience of fatigue across five chronic conditions. J Pain Symptom Manage. 2020;59(6):1320–1343. https://doi.org/10.1016/j.jpainsymman.2019.12.358.; Lim EJ, Ahn YC, Jang ES, Lee SW, Lee SWH, Son CG. Systematic review and meta-analysis of the prevalence of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME). J Transl Med. 2020;18(1):100. https://doi.org/10.1186/s12967-020-02269-0.; Valdez AR, Hancock EE, Adebayo S, Kiernicki DJ, Proskauer D, Attewell JR et al. Estimating prevalence, demographics, and costs of ME/CFS using large scale medical claims data and machine learning. Front Pediatr. 2019;6:412. https://doi.org/10.3389/fped.2018.00412.; Unger ER, Lin JS, Tian H, Natelson BH, Lange G, Vu D et al. Multi-site clinical assessment of myalgic encephalomyelitis/chronic fatigue syndrome (MCAM): design and implementation of a prospective/retrospective rolling cohort study. Am J Epidemiol. 2017;185(8):617–626. https://doi.org/10.1093/aje/kwx029.; Pendergrast T, Brown A, Sunnquist M, Jantke R, Newton JL, Strand EB et al. Housebound versus nonhousebound patients with myalgic encephalomyelitis and chronic fatigue syndrome. Chronic Illn. 2016;12(4):292–307. https://doi.org/10.1177/1742395316644770.; Bested AC, Marshall LM. Review of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: an evidence-based approach to diagnosis and management by clinicians. Rev Environ Health. 2015;30(4):223–249. https://doi.org/10.1515/reveh-2015-0026.; Clayton EW, Biaggionni I, Cockshell S, Vermeculen R, Snell C, Rove K. Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness. The National Academies Press; Washington, DC, USA: 2015. https://doi.org/10.17226/19012.; Rowe PC, Underhill RA, Friedman KJ, Gurwitt A, Medow MS, Schwartz MS et al. Myalgic encephalomyelitis/chronic fatigue syndrome diagnosis and management in young people: a primer. Front Pediatr. 2017;5:121. https://doi.org/10.3389/fped.2017.00121.; Bakken IJ, Tveito K, Gunnes N, Ghaderi S, Stoltenberg C, Trogstad L et al. Two age peaks in the incidence of chronic fatigue syndrome/myalgic encephalomyelitis: a population-based registry study from Norway 2008–2012. BMC Med. 2014;12:167. https://doi.org/10.1186/s12916-014-0167-5.; Stussman B, Williams A, Snow J, Gavin A, Scott R, Nath A, Walitt B. Characterization of post-exertional malaise in patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Front Neurol. 2020;11:1025. https://doi.org/10.3389/fneur.2020.01025.; van Campen CLMC, Verheugt FWA, Rowe PC, Visser FC. Orthostatic chronotropic incompetence in patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). IBRO Neurosci Rep. 2023;15:1–10. https://doi.org/10.1016/j.ibneur.2023.04.005.; Carruthers BM, Jain AK, de Meirleir KL, Peterson DL, Klimas NG, Lerner AM et al. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Clinical working case definition, diagnostic and treatment protocols. J Chronic Fatigue Syndr. 2003;11(1):7–115. https://doi.org/10.1300/J092v11n01_02.; Kingdon C, Lowe A, Shepherd C, Nacul L. What Primary Care Practitioners Need to Know about the New NICE Guideline for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in Adults. Healthcare. 2022;10(12):2438. https://doi.org/10.3390/healthcare10122438.; Rivera MC, Mastronardi C, Silva-Aldana CT, Arcos-Burgos M. Myalgic encephalomyelitis/chronic fatigue syndrome: a comprehensive review. Diagnostics (Basel). 2019;9(3):91. https://doi.org/10.3390/diagnostics9030091.; Naess H, Sundal E, Myhr K-M, Nyland HI. Postinfectious and chronic fatigue syndromes: clinical experience from a tertiary-referral centre in Norway. In Vivo. 2010;24(2):185–188. Available at: https://pubmed.ncbi.nlm.nih.gov/20363992/.; Hickie I, Davenport T, Wakefield D, Vollmer-Conna U, Cameron B, Vernon SD et al. Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study. BMJ. 2006;333(7568):575. https://doi.org/10.1136/bmj.38933.585764.AE.; Gil A, Hoag GE, Salerno JP, Hornig M, Klimas N, Selin LK. Identification of CD8 T-cell dysfunction associated with symptoms in myalgic encephalomyelitis/ chronic fatigue syndrome (ME/CFS) and Long COVID and treatment with a nebulized antioxidant/anti-pathogen agent in a retrospective case series. Brain Behav Immun Health. 2023;36:100720. https://doi.org/10.1016/j.bbih.2023.100720.; Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re’em Y et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinical Medicine. 2021;38:101019. https://doi.org/10.1016/j.eclinm.2021.101019.; Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021;594(7862):259–264. https://doi.org/10.1038/s41586-021-03553-9.; Taquet M, Dercon Q, Luciano S, Geddes JR, Husain M, Harrison PJ. Incidence, co-occurrence, and evolution of long-COVID features: a 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med. 2021;18(9):e1003773. https://doi.org/10.1371/journal.pmed.1003773.; Filler K, Lyon D, Bennett J, McCain N, Elswick R, Lukkahatai N, Saligan LN. Association of mitochondrial dysfunction and fatigue: a review of the literature. BBA Clin. 2014;1:12–23. https://doi.org/10.1016/j.bbacli.2014.04.001.; Blomberg J, Gottfries CG, Elfaitouri A, Rizwan M, Rosen A. Infection elicited autoimmunity and myalgic encephalomyelitis/chronic fatigue syndrome: an explanatory model. Front Immunol. 2018;9:229. https://doi.org/10.3389/fimmu.2018.00229.; Sotzny F, Blanco J, Capelli E, Castro-Marrero J, Steiner S, Murovska M et al. Myalgic encephalomyelitis/chronic fatigue syndrome – Evidence for an autoimmune disease. Autoimmun Rev. 2018;17(6):601–609. https://doi.org/10.1016/j.autrev.2018.01.009.; Mueller C, Lin JC, Sheriff S, Maudsley AA, Younger JW. Evidence of widespread metabolite abnormalities in myalgic encephalomyelitis/chronic fatigue syndrome: assessment with whole-brain magnetic resonance spectroscopy. Brain Imaging Behav. 2020;14(2):562–572. https://doi.org/10.1007/s11682-018-0029-4.; Naviaux RK, Naviaux JC, Li K, Bright AT, Alaynick WA, Wang L et al. Metabolic features of chronic fatigue syndrome. Proc Natl Acad Sci USA. 2016;113(37):5472–5480. https://doi.org/10.1073/pnas.1607571113.; Montoya JG, Holmes TH, Anderson JN, Maecker HT, Rosenberg-Hasson Y, Valencia IJ et al. Cytokine signature associated with disease severity in chronic fatigue syndrome patients. Proc Natl Acad Sci USA. 2017;114(34):7150–7158. https://doi.org/10.1073/pnas.1710519114.; Unger ER, Lin JS, Tian H, Gurbaxani BM, Boneva RS, Jones JF. Methods of applying the 1994 case definition of chronic fatigue syndrome – impact on classification and observed illness characteristics. Popul Health Metr. 2016;14:5. https://doi.org/10.1186/s12963-016-0077-1.; Hives L, Bradley A, Richards J, Sutton C, Selfe J, Basu B et al. Can physical assessment techniques aid diagnosis in people with chronic fatigue syndrome/myalgic encephalomyelitis? A diagnostic accuracy study. BMJ Open. 2017;7(11):e017521. https://doi.org/10.1136/bmjopen-2017-017521.; Bateman L, Bested AC, Bonilla HF, Chheda BV, Chu L, Curtin JM et al. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Essentials of Diagnosis and Management. Mayo Clin Proc. 2021;96(11):2861–2878. https://doi.org/10.1016/j.mayocp.2021.07.004.; Пизова НВ, Пизов АВ. Когнитивные нарушения и синдром хронической усталости. Нервные болезни. 2021;10–16. https://doi.org/10.24412/2226-0757-2021-12349.; Strand EB, Nacul L, Mengshoel AM, Helland IB, Grabowski P, Krumina A et al. Myalgic encephalomyelitis/chronic fatigue Syndrome (ME/CFS): Investigating care practices pointed out to disparities in diagnosis and treatment across European Union. PLoS ONE. 2019;14(12):e0225995. https://doi.org/10.1371/journal.pone.0225995.; Andersson G, Rozental A, Shafran R, Carlbring P. Long-term effects of internetsupported cognitive behaviour therapy. Expert Rev Neurother. 2018;18(1):21–28. https://doi.org/10.1080/14737175.2018.1400381.; Geraghty KJ, Blease C. Cognitive behavioural therapy in the treatment of chronic fatigue syndrome: A narrative review on efficacy and informed consent. J Health Psychol. 2018;23(1):127–138. https://doi.org/10.1177/1359105316667798.; Vink M, Vink-Niese A. The draft updated NICE guidance for ME/CFS highlights the unreliability of subjective outcome measures in non-blinded trials. J Health Psychol. 2022;27(1):9–12. https://doi.org/10.1177/1359105321990810.; Захаров ВВ. Виды памяти и клинические синдромы амнестических расстройств. Поведенческая неврология. 2022;(1):18–26. https://doi.org/10.46393/27129675_2022_1_18.; Ковальчук ВВ, Скоромец АА, Ковальчук ИВ, Стоянова ЕГ, Высоцкая МЛ, Мелихова ЕВ, Ильяйнен ЕВ. Влияние фенотропила на степень восстановления пациентов после перенесенного инсульта. Журнал неврологии и психиатрии им. С.С. Корсакова. 2010;12(2):38–40. Режим доступа: https://www.mediasphera.ru/issues/zhurnal-nevrologii-i-psikhiatrii-im-s-s-korsakova/2010/12/downloads/ru/031997-72982010127.; Бельская ГН, Деревянных ЕА, Макарова ЛД, Крылова ЛГ, Попов ДВ. Опыт применения фенотропила при лечении больных в остром периоде инфаркта головного мозга. Нервные болезни 2005;(1):25–28. Режим доступа: https://cyberleninka.ru/article/n/opyt-primeneniya-fenotropila-pri-lechenii-bolnyhv-ostrom-periode-infarkta-golovnogo-mozga?ysclid=lu58gnzxo3398804594.; Федин АИ, Амчеславская ЕВ, Красноперов ЕН, Белопасова АВ. Применение Фенотропила у больных с хронической ишемией мозга и умеренными когнитивными нарушениями. Результаты рандомизированного двойного слепого плацебо-контролируемого исследования. Нервные болезни. 2010;(3):22–30. Режим доступа: https://cyberleninka.ru/article/n/primeneniefenotropila-u-bolnyh-s-hronicheskoy-ishemiey-mozga-i-umerennymi-kognitivnymi-narusheniyami-rezultaty-randomizirovannogo/viewer.; Карабанов АВ, Шведков ВВ, Иллариошкин СН. Опыт применения Фенотропила при болезни Паркинсона. Нервные болезни. 2009;(4):29–32. Режим доступа: https://cyberleninka.ru/article/n/opyt-primeneniya-fenotropila-pri-bolezni-parkinsona?ysclid=lvc6a4okcr129622367.; Ахапкина ВИ, Федин АИ, Аведисова АС, Ахапкин РВ. Эффективность фенотропила при лечении астенического синдрома и синдрома хронической усталости. Нервные болезни. 2004;(3):28–32. Режим доступа: https://elibrary.ru/nctyie.; Девликамова ФИ. Эффективность и безопасность препарата Актитропил у пациентов с астеническим синдромом: результаты наблюдательной клинической программы. Нервные болезни. 2022;(4):8–18. Режим доступа: https://cyberleninka.ru/article/n/effektivnost-i-bezopasnost-preparata-aktitropil-u-patsientov-s-astenicheskim-sindromom-rezultaty-nablyudatelnoy-klinicheskoy.; Токарева ЕР, Логинова НБ. Возможности нейропротективной терапии препаратом Актитропил (фонтурацетам) у пациентов в постковидном периоде с коморбидной неврологической патологией. Нервные болезни. 2023;(3):62–68. https://doi.org/10.24412/2226-0757-2023-13008.; https://www.med-sovet.pro/jour/article/view/8208

الاتاحة: https://www.med-sovet.pro/jour/article/view/8208
https://doi.org/10.21518/ms2024-150

View record in BASE

8

Academic Journal

Outpatient management of patients with vascular cognitive impairment ; Амбулаторное ведение пациентов с сосудистыми когнитивными нарушениями

المؤلفون: N. V. Pizova, A. V. Pizov, Н. В. Пизова, А. В. Пизов

المصدر: Meditsinskiy sovet = Medical Council; № 12 (2024); 31–38 ; Медицинский Совет; № 12 (2024); 31–38 ; 2658-5790 ; 2079-701X

مصطلحات موضوعية: холина альфосцерат, cerebrovascular diseases, vascular risk factors, cerebral small vessel disease, choline alfoscerate, цереброваскулярные заболевания, сосудистые факторы риска, церебральная болезнь мелких сосудов

وصف الملف: application/pdf

Relation: https://www.med-sovet.pro/jour/article/view/8466/7444; Sagaro GG, Traini E, Amenta F. Activity of Choline Alphoscerate on Adult-Onset Cognitive Dysfunctions: A Systematic Review and Meta-Analysis. J Alzheimers Dis. 2023;92(1):59–70. https://doi.org/10.3233/jad-221189.; Crimmins EM, Kim JK, Langa KM, Weir DR. Assessment of cognition using surveys and neuropsychological assessment: the Health and Retirement Study and the Aging, Demographics, and Memory Study. J Gerontol B Psychol Sci Soc Sci. 2011;66(1 Suppl.):i162–171. https://doi.org/10.1093/geronb/gbr048.; Jia L, Du Y, Chu L, Zhang Z, Li F, Lyu D et al. Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study. Lancet Public Health. 2020;5(12):e661–e671. https://doi.org/10.1016/S2468-2667(20)30185-7.; Nelson ME, Jester DJ, Petkus AJ, Andel R. Cognitive Reserve, Alzheimer’s Neuropathology, and Risk of Dementia: A Systematic Review and Meta-Analysis. Neuropsychol Rev. 2021;31(2):233–250. https://doi.org/10.1007/s11065-021-09478-4.; Chertkow H. Diagnosis and treatment of dementia: introduction. Introducing a series based on the Third Canadian Consensus Conference on the Diagnosis and Treatment of Dementia. CMAJ. 2008;178(3):316–321. https://doi.org/10.1503/cmaj.070795.; Busse A, Angermeyer MC, Riedel-Heller SG. Progression of mild cognitive impairment to dementia: a challenge to current thinking. Br J Psychiatry. 2006;189(5):399–404. https://doi.org/10.1192/bjp.bp.105.014779.; Roh JH, Lee JH. Recent updates on subcortical ischemic vascular dementia. J Stroke. 2014;16(1):18–26. https://doi.org/10.5853/jos.2014.16.1.18.; Parra MA, Butler S, McGeown WJ, Brown Nicholls LA, Robertson DJ. Globalising strategies to meet global challenges: the case of ageing and dementia. J Glob Health. 2019;9(2):020310. https://doi.org/10.7189/jogh.09.020310.; Ardelt M. Are Older Adults Wiser Than College Students? A Comparison of Two Age Cohorts. J Adult Dev. 2010;17:193–207. https://doi.org/10.1007/s10804-009-9088-5.; Park DC, Lautenschlager G, Hedden T, Davidson NS, Smith AD, Smith PK. Models of visuospatial and verbal memory across the adult life span. Psychol Aging. 2002;17(2):299–320. https://doi.org/10.1037/0882-7974.17.2.299.; Johnson W, Logie RH, Brockmole JR.Working memory tasks differ in factor structure across age cohorts: Implications for dedifferentiation. Intelligence. 2010;38(5):513–528. https://doi.org/10.1016/j.intell.2010.06.005.; Salthouse TA. Trajectories of normal cognitive aging. Psychol Aging. 2019;34(1):17–24. https://doi.org/10.1037/pag0000288.; Fitzpatrick AL, Kuller LH, Ives DG, Lopez OL, Jagust W, Breitner JC et al. Incidence and prevalence of dementia in the Cardiovascular Health Study. J Am Geriatr Soc. 2004;52(2):195–204. https://doi.org/10.1111/j.1532-5415.2004.52058.x; Wolf PA. Contributions of the Framingham Heart Study to stroke and dementia epidemiologic research at 60 years. Arch Neurol. 2012;69(5):567–571. https://doi.org/10.1001/archneurol.2011.977.; Whitmer RA, Sidney S, Selby J, Johnston SC, Yaffe K. Midlife cardiovascular risk factors and risk of dementia in late life. Neurology. 2005;64(2):277–281. https://doi.org/10.1212/01.WNL.0000149519.47454.F2.; Dichgans M, Leys D. Vascular Cognitive Impairment. Circ Res. 2017;120(3):573–591. https://doi.org/10.1161/CIRCRESAHA.116.308426.; Caruso P, Signori R, Moretti R. Small vessel disease to subcortical dementia: a dynamic model, which interfaces aging, cholinergic dysregulation and the neurovascular unit. Vasc Health Risk Manag. 2019;15:259–281. https://doi.org/10.2147/VHRM.S190470.; Rundek T, Tolea M, Ariko T, Fagerli EA, Camargo CJ. Vascular Cognitive Impairment (VCI). Neurotherapeutics. 2022;19(1):68–88. https://doi.org/10.1007/s13311-021-01170-y.; Zlokovic BV, Gottesman RF, Bernstein KE, Seshadri S, McKee A, Snyder H et al. Vascular contributions to cognitive impairment and dementia (VCID): A report from the 2018 National Heart, Lung, and Blood Institute and National Institute of Neurological Disorders and Stroke Workshop. Alzheimers Dement. 2020;16(12):1714–1733. https://doi.org/10.1002/alz.12157.; Iadecola C. The pathobiology of vascular dementia. Neuron. 2013;80(4):844–866. https://doi.org/10.1016/j.neuron.2013.10.008.; Schneider JA, Arvanitakis Z, Bang W, Bennett DA. Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology. 2007;69(24):2197–2204. https://doi.org/10.1212/01.wnl.0000271090.28148.24.; Bélanger M, Allaman I, Magistretti PJ. Brain energy metabolism: focus on astrocyte-neuron metabolic cooperation. Cell Metab. 2011;14(6):724–738. https://doi.org/10.1016/j.cmet.2011.08.016.; Toth P, Tarantini S, Csiszar A, Ungvari Z. Functional vascular contributions to cognitive impairment and dementia: mechanisms and consequences of cerebral autoregulatory dysfunction, endothelial impairment, and neurovascular uncoupling in aging. Am J Physiol Heart Circ Physiol. 2017;312(1):H1–H20. https://doi.org/10.1152/ajpheart.00581.2016.; Duncombe J, Kitamura A, Hase Y, Ihara M, Kalaria RN, Horsburgh K. Chronic cerebral hypoperfusion: a key mechanism leading to vascular cognitive impairment and dementia. Closing the translational gap between rodent models and human vascular cognitive impairment and dementia. Clin Sci (Lond). 2017;131(19):2451–2468. https://doi.org/10.1042/CS20160727.; Park JH, Hong JH, Lee SW, Ji HD, Jung JA, Yoon KW et al. The effect of chronic cerebral hypoperfusion on the pathology of Alzheimer’s disease: A positron emission tomography study in rats. Sci Rep. 2019;9(1):14102. https://doi.org/10.1038/s41598-019-50681-4.; Duering M, Biessels GJ, Brodtmann A, Chen C, Cordonnier C, de Leeuw FE et al. Neuroimaging standards for research into small vessel diseaseadvances since 2013. Lancet Neurol. 2023;22(7):602–618. https://doi.org/10.1016/S1474-4422(23)00131-X.; Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12(8):822–838. https://doi.org/10.1016/S1474-4422(13)70124-8.; LADIS Study Group. 2001–2011: a decade of the LADIS (Leukoaraiosis And DISability) Study: what have we learned about white matter changes and small-vessel disease? Cerebrovasc Dis. 2011;32(6):577–588. https://doi.org/10.1159/000334498.; Lei C, Deng Q, Li H, Zhong L. Association Between Silent Brain Infarcts and Cognitive Function: A Systematic Review and Meta-Analysis. J Stroke Cerebrovasc Dis. 2019;28(9):2376–2387. https://doi.org/10.1016/j.jstrokecerebrovasdis.2019.03.036.; Qiu C, Cotch MF, Sigurdsson S, Jonsson PV, Jonsdottir MK, Sveinbjrnsdottir S et al. Cerebral microbleeds, retinopathy, and dementia: the AGES-Reykjavik Study. Neurology. 2010;75(24):2221–2228. https://doi.org/10.1212/WNL.0b013e3182020349.; Hachinski VC, Lassen NA, Marshall J. Multi-infarct dementia. A cause of mental deterioration in the elderly. Lancet. 1974;304(7874):207–210. https://doi.org/10.1016/s0140-6736(74)91496-2.; Graff-Radford J. Vascular Cognitive Impairment. Continuum (Minneap Minn). 2019;25(1):147–164. https://doi.org/10.1212/CON.0000000000000684.; Sonnen JA, Larson EB, Crane PK, Haneuse S, Li G, Schellenberg GD et al. Pathological correlates of dementia in a longitudinal, population-based sample of aging. Ann Neurol. 2007;62(4):406–413. https://doi.org/10.1002/ana.21208.; Tatemichi TK, Desmond DW, Prohovnik I. Strategic infarcts in vascular dementia. A clinical and brain imaging experience. Arzneimittelforschung. 1995;45(3A):371–385. Available at: https://pubmed.ncbi.nlm.nih.gov/7763329/.; Biesbroek JM, Kuijf HJ, van der Graaf Y, Vincken KL, Postma A, Mali WP et al. Association between subcortical vascular lesion location and cognition: a voxel-based and tract-based lesion-symptom mapping study. The SMART-MR study. PLoS ONE. 2013;8(4):e60541. https://doi.org/10.1371/journal.pone.0060541.; Benedictus MR, Hochart A, Rossi C, Boulouis G, Hénon H, van der Flier WM, Cordonnier C. Prognostic Factors for Cognitive Decline After Intracerebral Hemorrhage. Stroke. 2015;46(10):2773–2778. https://doi.org/10.1161/STROKEAHA.115.010200.; Cordonnier C, Al-Shahi Salman R, Wardlaw J. Spontaneous brain microbleeds: systematic review, subgroup analyses and standards for study design and reporting. Brain. 2007;130(8):1988–2003. https://doi.org/10.1093/brain/awl387.; Захаров ВВ. Диагностика и лечение сосудистых когнитивных нарушений. Клиницист. 2023;17(3):12–21. https://doi.org/10.17650/1818-8338-2023-17-3-K694.; Molad J, Kliper E, Korczyn AD, Ben Assayag E, Ben Bashat D, ShenharTsarfaty S e al. Only White Matter Hyperintensities Predicts Post-Stroke Cognitive Performances Among Cerebral Small Vessel Disease Markers: Results from the TABASCO Study. J Alzheimers Dis. 2017;56(4):1293–1299. https://doi.org/10.3233/JAD-160939.; Rasquin SM, Verhey FR, van Oostenbrugge RJ, Lousberg R, Lodder J. Demographic and CT scan features related to cognitive impairment in the first year after stroke. J Neurol Neurosurg Psychiatry. 2004;75(11):1562–1567. https://doi.org/10.1136/jnnp.2003.024190.; Debette S, Markus HS. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ. 2010;341:c3666. https://doi.org/10.1136/bmj.c3666.; Au R, Massaro JM, Wolf PA, Young ME, Beiser A, Seshadri S et al. Association of white matter hyperintensity volume with decreased cognitive functioning: the Framingham Heart Study. Arch Neurol. 2006;63(2):246–250. https://doi.org/10.1001/archneur.63.2.246.; Wright CB, Festa JR, Paik MC, Schmiedigen A, Brown TR, Yoshita M et al. White matter hyperintensities and subclinical infarction: associations with psychomotor speed and cognitive flexibility. Stroke. 2008;39(3):800–805. https://doi.org/10.1161/STROKEAHA.107.484147.; Leary MC, Saver JL. Annual incidence of first silent stroke in the United States: a preliminary estimate. Cerebrovasc Dis. 2003;16(3):280–285. https://doi.org/10.1159/000071128.; Smith EE, Saposnik G, Biessels GJ, Doubal FN, Fornage M, Gorelick PB et al. Prevention of Stroke in Patients With Silent Cerebrovascular Disease: A Scientific Statement for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2017;48(2):e44–e71. https://doi.org/10.1161/STR.0000000000000116.; Chojdak-Łukasiewicz J, Dziadkowiak E, Zimny A, Paradowski B. Cerebral small vessel disease: A review. Adv Clin Exp Med. 2021;30(3):349–356. https://doi.org/10.17219/acem/131216.; Wen W, Sachdev PS, Li JJ, Chen X, Anstey KJ. White matter hyperintensities in the forties: their prevalence and topography in an epidemiological sample aged 44–48. Hum Brain Mapp. 2009;30(4):1155–1167. https://doi.org/10.1002/hbm.20586.; De Leeuw FE, de Groot JC, Achten E, Oudkerk M, Ramos LM, Heijboer R et al. Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study. J Neurol Neurosurg Psychiatry. 2001;70(1):9–14. https://doi.org/10.1136/jnnp.70.1.9.; Zanon Zotin MC, Sveikata L, Viswanathan A, Yilmaz P. Cerebral small vessel disease and vascular cognitive impairment: from diagnosis to management. Curr Opin Neurol. 2021;34(2):246–257. https://doi.org/10.1097/WCO.0000000000000913.; O’Brien JT, Erkinjuntti T, Reisberg B, Roman G, Sawada T, Pantoni L et al. Vascular cognitive impairment. Lancet Neurol. 2003;2(2):89–98. https://doi.org/10.1016/s1474-4422(03)00305-3.; Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 2010;9(7):689–701. https://doi.org/10.1016/S1474-4422(10)70104-6.; Wardlaw JM, Smith C, Dichgans M. Small vessel disease: mechanisms and clinical implications. Lancet Neurol. 2019;18(7):684–696. https://doi.org/10.1016/S1474-4422(19)30079-1.; Staals J, Makin SD, Doubal FN, Dennis MS, Wardlaw JM. Stroke subtype, vascular risk factors, and total MRI brain small-vessel disease burden. Neurology. 2014;83(14):1228–1234. https://doi.org/10.1212/WNL.0000000000000837.; Xu X, Hilal S, Collinson SL, Chong EJ, Ikram MK, Venketasubramanian N, Chen CL. Association of Magnetic Resonance Imaging Markers of Cerebrovascular Disease Burden and Cognition. Stroke. 2015;46(10):2808–2814. https://doi.org/10.1161/STROKEAHA.115.010700.; Kolominsky-Rabas PL, Weber M, Gefeller O, Neundoerfer B, Heuschmann PU. Epidemiology of ischemic stroke subtypes according to TOAST criteria: incidence, recurrence, and long-term survival in ischemic stroke subtypes: a population-based study. Stroke. 2001;32(12):2735–2740. https://doi.org/10.1161/hs1201.100209.; Sachdev P, Kalaria R, O’Brien J, Skoog I, Alladi S, Black SE et al. Diagnostic criteria for vascular cognitive disorders: a VASCOG statement. Alzheimer Dis Assoc Disord. 2014;28(3):206–218. https://doi.org/10.1097/WAD.0000000000000034.; Litak J, Mazurek M, Kulesza B, Szmygin P, Litak J, Kamieniak P, Grochowski C. Cerebral Small Vessel Disease. Int J Mol Sci. 2020;21(24):9729. https://doi.org/10.3390/ijms21249729.; Blevins BL, Vinters HV, Love S, Wilcock DM, Grinberg LT, Schneider JA et al. Brain arteriolosclerosis. Acta Neuropathol. 2021;141(1):1–24. https://doi.org/10.1007/s00401-020-02235-6.; Greenberg SM, Bacskai BJ, Hernandez-Guillamon M, Pruzin J, Sperling R, van Veluw SJ. Cerebral amyloid angiopathy and Alzheimer disease – one peptide, two pathways. Nat Rev Neurol. 2020;16(1):30–42. https://doi.org/10.1038/s41582-019-0281-2.; Yuan L, Chen X, Jankovic J, Deng H. CADASIL: A NOTCH3-associated cerebral small vessel disease. J Adv Res. 2024.https://doi.org/10.1016/j.jare.2024.01.001.; Greenberg SM, Gurol ME, Rosand J, Smith EE. Amyloid angiopathy-related vascular cognitive impairment. Stroke. 2004;35(11 Suppl. 1):2616–2619. https://doi.org/10.1161/01.STR.0000143224.36527.44.; Hara K, Shiga A, Fukutake T, Nozaki H, Miyashita A, Yokoseki A et al. Association of HTRA1 mutations and familial ischemic cerebral smallvessel disease. N Engl J Med. 2009;360(17):1729–1739. https://doi.org/10.1056/NEJMoa0801560.; Chabriat H, Bousser MG. Neuropsychiatric manifestations in CADASIL. Dialogues Clin Neurosci. 2007;9(2):199–208. https://doi.org/10.31887/DCNS.2007.9.2/hchabriat.; Tikka S, Baumann M, Siitonen M, Pasanen P, Pöyhönen M, Myllykangas L et al. CADASIL and CARASIL. Brain Pathol. 2014;24(5):525–544. https://doi.org/10.1111/bpa.12181.; Forette F, Seux ML, Staessen JA, Thijs L, Babarskiene MR, Babeanu S et al. The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study. Arch Intern Med. 2002;162(18):2046–2052. https://doi.org/10.1001/archinte.162.18.2046.; Williamson JD, Pajewski NM, Auchus AP, Bryan RN, Chelune G, Cheung AK et al. Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia: A Randomized Clinical Trial. JAMA. 2019;321(6):553–561. https://doi.org/10.1001/jama.2018.21442.; Nasrallah IM, Pajewski NM, Auchus AP, Chelune G, Cheung AK, Cleveland ML et al. Association of Intensive vs Standard Blood Pressure Control With Cerebral White Matter Lesions. JAMA. 2019;322(6):524–534. https://doi.org/10.1001/jama.2019.10551.; Dufouil C, Chalmers J, Coskun O, Besançon V, Bousser MG, Guillon P et al. Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke: the PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy. Circulation. 2005;112(11):1644–1650. https://doi.org/10.1161/CIRCULATIONAHA.104.501163.; Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging – Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7(3):270–279. https://doi.org/10.1016/j.jalz.2011.03.008.; Gorelick PB, Scuteri A, Black SE, Decarli C, Greenberg SM, Iadecola C et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/ American Stroke Association. Stroke. 2011;42(9):2672–2713. https://doi.org/10.1161/STR.0b013e3182299496.; Traini E, Bramanti V, Amenta F. Choline alphoscerate (alpha-glycerylphosphoryl-choline) an old choline-containing phospholipid with a still interesting profile as cognition enhancing agent. Curr Alzheimer Res. 2013;10(10):1070–1079. https://doi.org/10.2174/15672050113106660173.; Hasselmo ME. The role of acetylcholine in learning and memory. Curr Opin Neurobiol. 2006;16(6):710–715. https://doi.org/10.1016/j.conb.2006.09.002.; Parnetti L, Amenta F, Gallai V. Choline alphoscerate in cognitive decline and in acute cerebrovascular disease: an analysis of published clinical data. Mech Ageing Dev. 2001;122(16):2041–2055. https://doi.org/10.1016/s0047-6374(01)00312-8.; Романова ИС, Кожанова ИН, Чак ТА. Холина альфосцерат в лечении неврологических нарушений. Здравоохранение (Минск). 2022;(10):52–59. Режим доступа: https://www.elibrary.ru/ioxwwb.; Ajenikoko MK, Ajagbe AO, Onigbinde OA, Okesina AA, Tijani AA. Review of Alzheimer’s disease drugs and their relationship with neuron-glia interaction. IBRO Neurosci Rep. 2022;14:64–76. https://doi.org/10.1016/j.ibneur.2022.11.005.; Yu JH, Kim LY, Kim JM, Park MJ, Park YS, Park NS, Yang WD. The effect of choline alphoscerate on non spatial memory and neuronal differentiation in a rat model of dual stress. Brain Res. 2022;1786:147900. https://doi.org/10.1016/j.brainres.2022.147900.; Barbagallo Sangiorgi G, Barbagallo M, Giordano M, Meli M, Panzarasa R. α-Glycerophosphocholine in the mental recovery of cerebral ischemic attacks. An Italian multicenter clinical trial. Ann N Y Acad Sci. 1994;717(1):253–269. https://doi.org/10.1111/j.1749-6632.1994.tb12095.x.; Di Perri R, Coppola G, Ambrosio LA, Grasso A, Puca FM, Rizzo M. A multicentre trial to evaluate the efficacy and tolerability of alphaglycerylphosphorylcholine versus cytosine diphosphocholine in patients with vascular dementia. J Int Med Res. 1991;19(4):330–341. https://doi.org/10.1177/030006059101900406.; Румянцева СА, Кравчук АА, Рыжова ДД. Терапия когнитивных расстройств у больных хронической ишемией головного мозга. РМЖ. 2007;(5):379–383. Режим доступа: https://www.rmj.ru/articles/nevrologiya/Terapiya_kognitivnyh_rasstroystv_u_bolynyh_hronicheskoy_ishemiey_golovnogo_mozga/.; Менделевич ЕГ, Сурженко ИЛ, Дунин ДН, Богданов ЭИ. Церетон в лечении когнитивных нарушений у больных дисциркуляторной и посттравматической энцефалопатией. РМЖ. 2009;(5):382–387. Режим доступа: https://www.rmj.ru/articles/nevrologiya/Cereton_v_lechenii_kognitivnyh_narusheniy__u_bolynyh_discirkulyatornoy_i_posttravmaticheskoy_encefalopatiey/.; Соловьева АВ, Чичановская ЛВ, Бахарева ОН, Брянцева МВ. Изучение эффективности препарата Церетон в лечении больных пожилого возраста, страдающих хронической ишемией головного мозга. РМЖ. 2009;(23):1522–1525. Режим доступа: https://www.rmj.ru/articles/nevrologiya/Izuchenie_effektivnosti_preparata_Cereton__v_lechenii_bolynyh_poghilogo_vozrasta__stradayuschih_hronicheskoy_ishemiey_golovnogo_mozga/.; Батышева ТТ, Нестерова ОС, Отческая ОВ, Хозова АА, Зайцев КС, Камчатнов ПР, Бойко АН. Применение Церетона у больных с умеренными когнитивными расстройствами сосудистого генеза. Трудный пациент. 2009;7(4-5):10–12. Режим доступа: https://www.elibrary.ru/ogaixn.; Traini E, Carotenuto A, Fasanaro AM, Amenta F. Volume Analysis of Brain Cognitive Areas in Alzheimer’s Disease: Interim 3-Year Results from the ASCOMALVA Trial. J Alzheimers Dis. 2020;76(1):317–329. https://doi.org/10.3233/jad-190623.; Levin OS, Batukaeva LA, Anikina MA, Yunishchenko NA. Efficacy and safety of choline alphoscerate (cereton) in patients with Parkinson’s disease with cognitive impairments. Neurosci Behav Physiol. 2011;4:47–51. https://doi.org/10.1007/s11055-010-9377-2.; Salvadori E, Poggesi A, Donnini I, Rinnoci V, Chiti G, Squitieri M et al. Efficacy and Safety of the Association of Nimodipine and Choline Alphoscerate in the Treatment of Cognitive Impairment in Patients with Cerebral Small Vessel Disease. The CONIVaD Trial. Drugs Aging. 2021;38(6):481–491. https://doi.org/10.1007/s40266-021-00852-8; https://www.med-sovet.pro/jour/article/view/8466

الاتاحة: https://www.med-sovet.pro/jour/article/view/8466
https://doi.org/10.21518/ms2024-311

View record in BASE

9

Academic Journal

Repeated ischemic stroke and its prevention ; Повторный ишемический инсульт и его профилактика

المؤلفون: N. V. Pizova, A. V. Pizov, Н. В. Пизова, А. В. Пизов

المصدر: Meditsinskiy sovet = Medical Council; № 12 (2024); 8–14 ; Медицинский Совет; № 12 (2024); 8–14 ; 2658-5790 ; 2079-701X

مصطلحات موضوعية: дипиридамол, lacunar stroke, cardioembolic stroke, recurrent stroke, epidemiology, risk factors, secondary prevention, antiplatelet therapy, dipyridamole, лакунарный инсульт, кардиоэмболический инсульт, повторный инсульт, эпидемиология, факторы риска, вторичная профилактика, антитромбоцитарная терапия

وصف الملف: application/pdf

Relation: https://www.med-sovet.pro/jour/article/view/8459/7437; Kolmos M, Christoffersen L, Kruuse C. Recurrent Ischemic Stroke – A Systematic Review and Meta-Analysis. J Stroke Cerebrovasc Dis. 2021;30(8):105935. https://doi.org/10.1016/j.jstrokecerebrovasdis.2021.105935.; Kolominsky-Rabas PL, Weber M, Gefeller O, Neundoerfer B, Heuschmann PU. Epidemiology of ischemic stroke subtypes according to TOAST criteria: incidence, recurrence, and long-term survival in ischemic stroke subtypes: a population-based study. Stroke. 2001;32(12):2735–2740. https://doi.org/10.1161/hs1201.100209.; Hénon H, Vroylandt P, Durieu I, Pasquier F, Leys D. Leukoaraiosis more than dementia is a predictor of stroke recurrence. Stroke. 2003;34(12):2935–2940. https://doi.org/10.1161/01.STR.0000103747.58719.59.; Modrego PJ, Mainar R, Turull L. Recurrence and survival after first-ever stroke in the area of Bajo Aragon, Spain. A prospective cohort study. J Neurol Sci. 2004;224(1-2):49–55. https://doi.org/10.1016/j.jns.2004.06.002.; Shin DH, Lee PH, Bang OY. Mechanisms of recurrence in subtypes of ischemic stroke: a hospital-based follow-up study. Arch Neurol. 2005;62(8):1232–1237. https://doi.org/10.1001/archneur.62.8.1232.; Hata J, Tanizaki Y, Kiyohara Y, Kato I, Kubo M, Tanaka K et al. Ten year recurrence after first ever stroke in a Japanese community: the Hisayama study. J Neurol Neurosurg Psychiatry. 2005;76(3):368–372. https://doi.org/10.1136/jnnp.2004.038166.; Wang Y, Xu J, Zhao X, Wang D, Wang C, Liu L et al. Association of hypertension with stroke recurrence depends on ischemic stroke subtype. Stroke. 2013;44(5):1232–1237. https://doi.org/10.1161/STROKEAHA.111.000302.; Cabral NL, Muller M, Franco SC, Longo A, Moro C, Nagel V et al. Three-year survival and recurrence after first-ever stroke: the Joinville stroke registry. BMC Neurol. 2015;15:70. https://doi.org/10.1186/s12883-015-0317-1.; Kumral E, Güllüoğlu H, Alakbarova N, Deveci EE, Çolak AY, Çağında AD et al. Cognitive Decline in Patients with Leukoaraiosis Within 5 Years after Initial Stroke. J Stroke Cerebrovasc Dis. 2015;24(10):2338–2347. https://doi.org/10.1016/j.jstrokecerebrovasdis.2015.06.012.; Kang K, Park TH, Kim N, Jang MU, Park SS, Park JM et al. Recurrent Stroke, Myocardial Infarction, and Major Vascular Events during the First Year after Acute Ischemic Stroke: The Multicenter Prospective Observational Study about Recurrence and Its Determinants after Acute Ischemic Stroke I. J Stroke Cerebrovasc Dis. 2016;25(3):656–664. https://doi.org/10.1016/j.jstrokecerebrovasdis.2015.11.036.; Saber H, Thrift AG, Kapral MK, Shoamanesh A, Amiri A, Farzadfard MT et al. Incidence, recurrence, and long-term survival of ischemic stroke subtypes: A population-based study in the Middle East. Int J Stroke. 2017;12(8):835–843. https://doi.org/10.1177/1747493016684843.; Lange MC, Ribas G, Scavasine V, Ducci RD, Mendes DC, Zétola VHF et al. Stroke recurrence in the different subtypes of ischemic stroke. The importance of the intracranial disease. Arq Neuropsiquiatr. 2018;76(10):649–653. https://doi.org/10.1590/0004-282X20180095.; Bjerkreim AT, Khanevski AN, Thomassen L, Selvik HA, Waje-Andreassen U, Naess H, Logallo N. Five-year readmission and mortality differ by ischemic stroke subtype. J Neurol Sci. 2019;403:31–37. https://doi.org/10.1016/j.jns.2019.06.007.; Huang ZX, Lin XL, Lu HK, Liang XY, Fan LJ, Liu XT. Lifestyles correlate with stroke recurrence in Chinese inpatients with first-ever acute ischemic stroke. J Neurol. 2019;266(5):1194–1202. https://doi.org/10.1007/s00415-019-09249-5.; Rücker V, Heuschmann PU, O’Flaherty M, Weingärtner M, Hess M, Sedlak C et al. Twenty-Year Time Trends in Long-Term Case-Fatality and Recurrence Rates After Ischemic Stroke Stratified by Etiology. Stroke. 2020;51(9):2778–2785. https://doi.org/10.1161/STROKEAHA.120.029972.; Arsava EM, Kim GM, Oliveira-Filho J, Gungor L, Noh HJ, Lordelo Mde J et al. Prediction of Early Recurrence After Acute Ischemic Stroke. JAMA Neurol. 2016;73(4):396–401. https://doi.org/10.1001/jamaneurol.2015.4949.; Moerch-Rasmussen A, Nacu A, Waje-Andreassen U, Thomassen L, Naess H. Recurrent ischemic stroke is associated with the burden of risk factors. Acta Neurol Scand. 2016;133(4):289–294. https://doi.org/10.1111/ane.12457.; Lin B, Zhang Z, Mei Y, Wang C, Xu H, Liu L, Wang W. Cumulative risk of stroke recurrence over the last 10 years: a systematic review and meta-analysis. Neurol Sci. 2021;42(1):61–71. https://doi.org/10.1007/s10072-020-04797-5.; Skajaa N, Adelborg K, Horváth-Puhó E, Rothman KJ, Henderson VW, Thygesen LC, Sørensen HT. Risks of Stroke Recurrence and Mortality After First and Recurrent Strokes in Denmark: A Nationwide Registry Study. Neurology. 2022;98(4):e329–e342. https://doi.org/10.1212/WNL.0000000000013118.; Ha BJ, Kang SM, Choi BM, Cheong JH, Ryu JI, Won YD, Han MH. Stroke recurrence and osteoporotic conditions in postmenopausal patients with atherosclerotic ischemic stroke. Heliyon. 2024;10(9):e30196. https://doi.org/10.1016/j.heliyon.2024.e30196.; Jørgensen HS, Nakayama H, Reith J, Raaschou HO, Olsen TS. Stroke recurrence: predictors, severity, and prognosis. The Copenhagen Stroke Study. Neurology. 1997;48(4):891–895. https://doi.org/10.1212/wnl.48.4.891.; Mohan KM, Crichton SL, Grieve AP, Rudd AG, Wolfe CD, Heuschmann PU. Frequency and predictors for the risk of stroke recurrence up to 10 years after stroke: the South London Stroke Register. J Neurol Neurosurg Psychiatry. 2009;80(9):1012–1018. https://doi.org/10.1136/jnnp.2008.170456.; Hankey GJ, Jamrozik K, Broadhurst RJ, Forbes S, Burvill PW, Anderson CS, Stewart-Wynne EG. Long-term risk of first recurrent stroke in the Perth Community Stroke Study. Stroke. 1998;29(12):2491–500. https://doi.org/10.1161/01.str.29.12.2491.; Pennlert J, Eriksson M, Carlberg B, Wiklund PG. Long-term risk and predictors of recurrent stroke beyond the acute phase. Stroke. 2014;45(6):1839–1841. https://doi.org/10.1161/STROKEAHA.114.005060.; Cheng YY, Leu HB, Chen TJ, Chen CL, Kuo CH, Lee SD, Kao CL. Metformininclusive therapy reduces the risk of stroke in patients with diabetes: a 4-year follow-up study. J Stroke Cerebrovasc Dis. 2014;23(2):e99–105. https://doi.org/10.1016/j.jstrokecerebrovasdis.2013.09.001.; Shani SD, Varma RP, Sarma SP, Sreelakshmi RS, Harikrishnan R, Kutty VR, Sylaja PN. Treatment in a Stroke Unit and Risk Factor Control Reduce Recurrent Stroke Risk. Cerebrovasc Dis Extra. 2022;12(2):85–92. https://doi.org/10.1159/000525716.; Caprio FZ, Sorond FA. Cerebrovascular Disease: Primary and Secondary Stroke Prevention. Med Clin North Am. 2019;103(2):295–308. https://doi.org/10.1016/j.mcna.2018.10.001.; Scott CA, Li L, Rothwell PM. Diverging Temporal Trends in Stroke Incidence in Younger vs Older People: A Systematic Review and Meta-analysis. JAMA Neurol. 2022;79(10):1036–1048. https://doi.org/10.1001/jamaneurol.2022.1520.; Пизов НА, Скачкова ОА, Пизова НВ, Баранова НС. Традиционные и редкие причины ишемического инсульта у лиц 18–50 лет. Consilium Medicum. 2021;23(2):122–126. Режим доступа: https://consilium.orscience.ru/2075-1753/article/view/95390.; George MG, Tong X, Bowman BA. Prevalence of Cardiovascular Risk Factors and Strokes in Younger Adults. JAMA Neurol. 2017;74(6):695–703. https://doi.org/10.1001/jamaneurol.2017.0020.; Пизов НА, Баранова НС, Пизова НВ, Бакучева МВ. Лакунарный инсульт у мужчин молодого возраста. РМЖ. Медицинское обозрение. 2023;7(10):614–619. https://doi.org/10.32364/2587-6821-2023-7-10-1.; Пизов НА, Баранова НС. Ишемический инсульт у мужчин 18–50 лет. Журнал неврологии и психиатрии им. С.С. Корсакова. 2024;124(3-2):5–11. https://doi.org/10.17116/jnevro20241240325.; Arntz RM, van Alebeek ME, Synhaeve NE, van Pamelen J, Maaijwee NA, Schoonderwaldt H et al. The very long-term risk and predictors of recurrent ischaemic events after a stroke at a young age: The FUTURE study. Eur Stroke J. 2016;1(4):337–345. https://doi.org/10.1177/2396987316673440.; Mustanoja S, Putaala J, Gordin D, Tulkki L, Aarnio K, Pirinen J et al. AcutePhase Blood Pressure Levels Correlate With a High Risk of Recurrent Strokes in Young-Onset Ischemic Stroke. Stroke. 2016;47(6):1593–1598. https://doi.org/10.1161/STROKEAHA.116.012944.; M’barek L, Sakka S, Megdiche F, Farhat N, Maalla K, Turki D et al. Traditional risk factors and combined genetic markers of recurrent ischemic stroke in adults. J Thromb Haemost. 2021;19(10):2596–2604. https://doi.org/10.1111/jth.15448.; Putaala J, Haapaniemi E, Metso AJ, Metso TM, Artto V, Kaste M, Tatlisumak T. Recurrent ischemic events in young adults after first-ever ischemic stroke. Ann Neurol. 2010;68(5):661–671. https://doi.org/10.1002/ana.22091.; Li F, Yang L, Yang R, Xu W, Chen FP, Li N, Zhang JB. Ischemic Stroke in Young Adults of Northern China: Characteristics and Risk Factors for Recurrence. Eur Neurol. 2017;77(3-4):115–122. https://doi.org/10.1159/000455093.; Zhao M, Deng X, Gao F, Zhang D, Wang S, Zhang Y et al. Ischemic Stroke in Young Adults with Moyamoya Disease: Prognostic Factors for Stroke Recurrence and Functional Outcome after Revascularization. World Neurosurg. 2017;103:161–167. https://doi.org/10.1016/j.wneu.2017.03.146.; Yuan K, Chen J, Xu P, Zhang X, Gong X, Wu M et al. A Nomogram for Predicting Stroke Recurrence Among Young Adults. Stroke. 2020;51(6):1865–1867. https://doi.org/10.1161/STROKEAHA.120.029740.; Divišová P, Šaňák D, Král M, Bártková A, Hutyra M, Zapletalová J et al. Young cryptogenic ischemic stroke: A descriptive analysis of clinical and laboratory characteristics, outcomes and stroke recurrence. J Stroke Cerebrovasc Dis. 2020;29(9):105046. https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.105046.; Chen Y, Wright N, Guo Y, Turnbull I, Kartsonaki C, Yang L et al. Mortality and recurrent vascular events after first incident stroke: a 9-year community-based study of 0·5 million Chinese adults. Lancet Glob Health. 2020;8(4):e580–e590. https://doi.org/10.1016/S2214-109X(20)30069-3.; Toni D, Di Angelantonio E, Di Mascio MT, Vinisko R, Bath PM. Types of stroke recurrence in patients with ischemic stroke: a substudy from the PRoFESS trial. Int J Stroke. 2014;9(7):873–878. https://doi.org/10.1111/ijs.12150.; Del Brutto VJ, Diener HC, Easton JD, Granger CB, Cronin L, Kleine E et al. Predictors of Recurrent Stroke After Embolic Stroke of Undetermined Source in the RE-SPECT ESUS Trial. J Am Heart Assoc. 2022;11(11):e023545. https://doi.org/10.1161/JAHA.121.023545.; Kauw F, Takx RAP, de Jong HWAM, Velthuis BK, Kappelle LJ, Dankbaar JW. Clinical and Imaging Predictors of Recurrent Ischemic Stroke: A Systematic Review and Meta-Analysis. Cerebrovasc Dis. 2018;45(5-6):279–287. https://doi.org/10.1159/000490422.; Flach C, Muruet W, Wolfe CDA, Bhalla A, Douiri A. Risk and Secondary Prevention of Stroke Recurrence: A Population-Base Cohort Study. Stroke. 2020;51(8):2435–2444. https://doi.org/10.1161/STROKEAHA.120.028992.; Soda T, Nakayasu H, Maeda M, Kusumi M, Kowa H, Awaki E et al. Stroke recurrence within the first year following cerebral infarction – Tottori University Lacunar Infarction Prognosis Study (TULIPS). Acta Neurol Scand. 2004;110(6):343–349. https://doi.org/10.1111/j.1600-0404.2004.00290.x.; Kang DW, Han MK, Kim HJ, Sohn H, Kim BJ, Kwon SU et al. Silent new ischemic lesions after index stroke and the risk of future clinical recurrent stroke. Neurology. 2016;86(3):277–285. https://doi.org/10.1212/WNL.0000000000002289.; Andersen SD, Skjøth F, Yavarian Y, Bach FW, Lip GY, Larsen TB. Multiple Silent Lacunes Are Associated with Recurrent Ischemic Stroke. Cerebrovasc Dis. 2016;42(1-2):73–80. https://doi.org/10.1159/000445196.; Bangad A, Abbasi M, de Havenon A. Secondary Ischemic Stroke Prevention. Neurotherapeutics. 2023;20(3):721–731. https://doi.org/10.1007/s13311-023-01352-w.; Ní Chróinín D, Asplund K, Åsberg S, Callaly E, Cuadrado-Godia E, Díez-Tejedor E et al. Statin therapy and outcome after ischemic stroke: systematic review and meta-analysis of observational studies and randomized trials. Stroke. 2013;44(2):448–456. https://doi.org/10.1161/STROKEAHA.112.668277.; Antithrombotic Trialists’ Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002;324(7329):71–86. https://doi.org/10.1136/bmj.324.7329.71.; Lakhan SE, Sapko MT. Blood pressure lowering treatment for preventing stroke recurrence: a systematic review and meta-analysis. Int Arch Med. 2009;2(1):30. https://doi.org/10.1186/1755-7682-2-30.; Gubitz G, Counsell C, Sandercock P, Signorini D. Anticoagulants for acute ischaemic stroke. Cochrane Database Syst Rev. 2000;(2):CD000024. https://doi.org/10.1002/14651858.CD000024.; Пизова НВ. Антитромбоцитарная терапия в профилактике повторного ишемического инсульта. Медицинский совет. 2023;(23):98–104. https://doi.org/10.21518/ms2023-459.; Kleindorfer DO, Towfighi A, Chaturvedi S, Cockroft KM, Gutierrez J, Lombardi-Hill D et al. 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association. Stroke. 2021;52(7):e364–e467. https://doi.org/10.1161/STR.0000000000000375.; Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K et al. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2019;50(12):e344–e418. https://doi.org/10.1161/STR.0000000000000211.; Naqvi IA, Kamal AK, Rehman H. Multiple versus fewer antiplatelet agents for preventing early recurrence after ischaemic stroke or transient ischaemic attack. Cochrane Database Syst Rev. 2020;8(8):CD009716. https://doi.org/10.1002/14651858.CD009716.pub2.; Sandercock PA, Counsell C, Tseng MC, Cecconi E. Oral antiplatelet therapy for acute ischaemic stroke. Cochrane Database Syst Rev. 2014;(3):CD000029. https://doi.org/10.1002/14651858.CD000029.pub3.; Hackam DG, Spence JD. Antiplatelet Therapy in Ischemic Stroke and Transient Ischemic Attack. Stroke. 2019;50(3):773–778. https://doi.org/10.1161/STROKEAHA.118.023954.; Johnston SC, Easton JD, Farrant M, Barsan W, Conwit RA, Elm JJ et al. Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA. N Engl J Med. 2018;379(3):215–225. https://doi.org/10.1056/NEJMoa1800410.; Shaban A, Monlezun DJ, Rincon N, Tiu J, Valmoria M, Martin-Schild S. Safety and Efficacy of Acute Clopidogrel Load in Patients with Moderate and Severe Ischemic Strokes. Stroke Res Treat. 2016:8915764. https://doi.org/10.1155/2016/8915764.; Diener HC, Bogousslavsky J, Brass LM, Cimminiello C, Csiba L, Kaste M et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet. 2004;364(9431):331–337. https://doi.org/10.1016/S0140-6736(04)16721-4.; Harker LA, Kadatz RA. Mechanism of action of dipyridamole. Thromb Res Suppl. 1983;4:39–46. https://doi.org/10.1016/0049-3848(83)90356-0.; Sacco RL, Diener HC, Yusuf S, Cotton D, Ounpuu S, Lawton WA et al. Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med. 2008;359(12):1238–1251. https://doi.org/10.1056/NEJMoa0805002.; Halkes PH, Gray LJ, Bath PM, Diener HC, Guiraud-Chaumeil B, Yatsu FM, Algra A. Dipyridamole plus aspirin versus aspirin alone in secondary prevention after TIA or stroke: a meta-analysis by risk. J Neurol Neurosurg Psychiatry. 2008;79(11):1218–1223. https://doi.org/10.1136/jnnp.2008.143875.; Barlas RS, Loke YK, Mamas MA, Bettencourt-Silva JH, Ford I, Clark AB et al. Effect of Antiplatelet Therapy (Aspirin + Dipyridamole Versus Clopidogrel) on Mortality Outcome in Ischemic Stroke. Am J Cardiol. 2018;122(6):1085–1090. https://doi.org/10.1016/j.amjcard.2018.05.043.; Diener HC, Cunha L, Forbes C, Sivenius J, Smets P, Lowenthal A. European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci. 1996;143(1-2):1–13. https://doi.org/10.1016/s0022-510x(96)00308-5.; De Schryver EL, Algra A, van Gijn J. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease. Cochrane Database Syst Rev. 2007;(3):CD001820. https://doi.org/10.1002/14651858.CD001820.pub3.; Diener HC, Sacco RL, Yusuf S, Cotton D, Ounpuu S, Lawton WA et al. Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebocontrolled study. Lancet Neurol. 2008;7(10):875–884. https://doi.org/10.1016/S1474-4422(08)70198-4.; Halkes PH, van Gijn J, Kappelle LJ, Koudstaal PJ, Algra A. Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial. Lancet. 2006;367(9523):1665–1673. https://doi.org/10.1016/S0140-6736(06)68734-5.; Second European Stroke Prevention Study. ESPS-2 Working Group. J Neurol. 1992;239(6):299–301. https://doi.org/10.1007/BF00867583.; The European Stroke Prevention Study (ESPS). Principal end-points. The ESPS Group. Lancet. 1987;330(8572):1351–1354. https://doi.org/10.1016/S0140-6736(87)91254-2.; Ковальчук ВВ. Вторичная профилактика инсультов как неотъемлемая часть общего реабилитационного процесса. Эффективная фармакотерапия. 2017;(19):52–61. Режим доступа: https://umedp.ru/articles/vtorichnaya_profilaktika_insultov_kak_neotemlemaya_chast_obshchego_reabilitatsionnogo_protsessa_.html.; https://www.med-sovet.pro/jour/article/view/8459

الاتاحة: https://www.med-sovet.pro/jour/article/view/8459
https://doi.org/10.21518/ms2024-261

View record in BASE

10

Academic Journal

Acute stress-induced disorders in general practice ; Острые стресс-индуцированные состояния в общей практике

المؤلفون: N. V. Pizova, A. V. Pizov, Н. В. Пизова, А. В. Пизов

المصدر: Meditsinskiy sovet = Medical Council; № 21 (2023); 89-94 ; Медицинский Совет; № 21 (2023); 89-94 ; 2658-5790 ; 2079-701X

مصطلحات موضوعية: комбинированные растительные средства, anxiety, stress-induced disorders, therapeutic approaches, combined herbal medicines, тревога, стресс-индуцированные состояния, терапевтические подходы

وصف الملف: application/pdf

Relation: https://www.med-sovet.pro/jour/article/view/7937/7049; Varma P, Junge M, Meaklim H, Jackson ML. Younger people are more vulnerable to stress, anxiety and depression during COVID-19 pandemic: A global cross-sectional survey. Prog Neuropsychopharmacol Biol Psychiatry. 2021;109:110236. https://doi.org/10.1016/j.pnpbp.2020.110236.; Пизова НВ, Пизов АВ. Панические и депрессивные расстройства в клинической практике. Поликлиника. 2020;(6):16–19. Режим доступа: https://www.poliklin.ru/imagearticle/20206/16-19.pdf.; Kessler RC, Sonnega A, Bromet E, Hughes M, Nelson CB. Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry. 1995;52(12): 1048–1060. https://doi.org/10.1001/archpsyc.1995.03950240066012.; Baxter AJ, Scott KM, Vos T, Whiteford HA. Global prevalence of anxiety disorders: a systematic review and meta-regression. Psychol Med. 2013;43(5):897–910. https://doi.org/10.1017/S003329171200147X.; Scott A, Cook JL, Hart DA, Walker DC, Duronio V, Khan KM. Tenocyte responses to mechanical loading in vivo: a role for local insulin-like growth factor 1 signaling in early tendinosis in rats. Arthritis Rheum. 2007;56(3):871–881. https://doi.org/10.1002/art.22426.; Juster RP, McEwen BS, Lupien SJ. Allostatic load biomarkers of chronic stress and impact on health and cognition. Neurosci Biobehav Rev. 2010;35(1):2–16. https://doi.org/10.1016/j.neubiorev.2009.10.002.; McEwen BS, Wingfield JC. What is in a name? Integrating homeostasis, allostasis and stress. Horm Behav. 2010;57(2):105–111. https://doi.org/10.1016/j.yhbeh.2009.09.011.; Karatsoreos IN, McEwen BS. Psychobiological allostasis: resistance, resilience and vulnerability. Trends Cogn Sci. 2011;15(12):576–584. https://doi.org/10.1016/j.tics.2011.10.005.; Selye H. Stress and the general adaptation syndrome. Br Med J. 1950;1(4667):1383–1392. https://doi.org/10.1136/bmj.1.4667.1383.; Vincze J, Vincze-Tiszay G. The physiological aspects of the stress. J Med Biomed Appl Sci. 2020;8(10):529–534. https://doi.org/10.15520/jmbas.v8i10.256.; Senanayake GB, Arambepola C. Understanding chronic stress: A narrative review of literature. J Coll Community Physicians Sri Lanka. 2019;25(1):30–36. https://doi.org/10.4038/jccpsl.v25i1.8196.; Aich P, Potter AA, Griebel PJ. Modern approaches to understanding stress and disease susceptibility: A review with special emphasis on respiratory disease. Int J Gen Med. 2009;2:19–32. https://doi.org/10.2147/ijgm.s4843.; Vincze J, Vincze-Tiszay G. Some biophysical aspects of the stress. Int J Recent Innov Med Clin Res. 2020;2(1):37–43. https://doi.org/10.5281/zenodo.3713319.; Bustamante-Sánchez Á, Tornero-Aguilera JF, Fernández-Elías VE, Hormeño-Holgado AJ, Dalamitros AA, Clemente-Suárez VJ. Effect of Stress on Autonomic and Cardiovascular Systems in Military Population: A Systematic Review. Cardiol Res Pract. 2020;2020:7986249. https://doi.org/10.1155/2020/7986249.; Sánchez-Molina J, Robles-Pérez JJ, Clemente-Suárez VJ. Assessment of Psychophysiological Response and Specific Fine Motor Skills in Combat Units. J Med Syst. 2018;42(4):67. https://doi.org/10.1007/s10916-018-0922-9.; Ganzel BL, Morris PA, Wethington E. Allostasis and the human brain: Integrating models of stress from the social and life sciences. Psychol Rev. 2010;117(1):134–174. https://doi.org/10.1037/a0017773.; Bertilsson J, Niehorster DC, Fredriksson P, Dahl M, Granér S, Fredriksson O et al. Towards systematic and objective evaluation of police officer performance in stressful situations. Police Pract Res. 2020;21(6):655–669. https://doi.org/10.1080/15614263.2019.1666006.; Phillips-Wren G, Adya M. Decision making under stress: The role of information overload, time pressure, complexity, and uncertainty. J Decis Syst. 2020;29(1):213–225. https://doi.org/10.1080/12460125.2020.1768680.; Эбзеева ЕЮ, Полякова ОА. Стресс и стресс-индуцированные расстройства. Медицинский совет. 2022;16(2):127–133. https://doi.org/10.21518/2079-701X-2022-16-2-127-133.; Taverniers J, Smeets T, Van Ruysseveldt J, Syroit J, von Grumbkow J. The risk of being shot at: Stress, cortisol secretion, and their impact on memory and perceived learning during reality-based practice for armed officers. Int J Stress Manag. 2011;(18):113–132. https://doi.org/10.1037/A0023742.; Kelley DC, Siegel E, Wormwood JB. Understanding Police Performance Under Stress: Insights From the Biopsychosocial Model of Challenge and Threat. Front Psychol. 2019;10:1800. https://doi.org/10.3389/fpsyg.2019.01800.; Perrin M, Vandeleur CL, Castelao E, Rothen S, Glaus J, Vollenweider P, Preisig M. Determinants of the development of post-traumatic stress disorder, in the general population. Soc Psychiatry Psychiatr Epidemiol. 2014;49(3):447–457. https://doi.org/10.1007/s00127-013-0762-3.; Bryant RA. Acute stress disorder as a predictor of posttraumatic stress disorder: a systematic review. J Clin Psychiatry. 2011;72(2):233–239. https://doi.org/10.4088/JCP.09r05072blu.; Cool J, Zappetti D. The Physiology of Stress. In: Zappetti D, Avery J (eds). Medical Student Well-Being. Springer, Cham; 22019, рр. 1–15. https://doi.org/10.1007/978-3-030-16558-1_1.; Mücke M, Ludyga S, Colledge F, Pühse U, Gerber M. Association of Exercise with Inhibitory Control and Prefrontal Brain Activity Under Acute Psychosocial Stress. Brain Sci. 2020;10(7):439. https://doi.org/10.3390/brainsci10070439.; Andersen JP, Di Nota PM, Beston B, Boychuk EC, Gustafsberg H, Poplawski S, Arpaia J. Reducing Lethal Force Errors by Modulating Police Physiology. J Occup Environ Med. 2018;60(10):867–874. https://doi.org/10.1097/JOM.0000000000001401.; Thayer JF, Hansen AL, Saus-Rose E, Johnsen BH. Heart rate variability, prefrontal neural function, and cognitive performance: the neurovisceral integration perspective on self-regulation, adaptation, and health. Ann Behav Med. 2009;37(2):141–153. https://doi.org/10.1007/s12160-009-9101-z.; Anderson GS, Di Nota PM, Metz GAS, Andersen JP. The Impact of Acute Stress Physiology on Skilled Motor Performance: Implications for Policing. Front Psychol. 2019;10:2501. https://doi.org/10.3389/fpsyg.2019.02501.; Thompson AG, Swain DP, Branch JD, Spina RJ, Grieco CR. Autonomic response to tactical pistol performance measured by heart rate variability. J Strength Cond Res. 2015;29(4):926–933. https://doi.org/10.1519/JSC.0000000000000615.; McEwen BS, Bowles NP, Gray JD, Hill MN, Hunter RG, Karatsoreos IN, Nasca C. Mechanisms of stress in the brain. Nat Neurosci. 2015;18(10):1353–1363. https://doi.org/10.1038/nn.4086.; Duman RS, Aghajanian GK, Sanacora G, Krystal JH. Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants. Nat Med. 2016;22(3):238–249. https://doi.org/10.1038/nm.4050.; Murrough JW, Abdallah CG, Mathew SJ. Targeting glutamate signaling in depression: progress and prospects. Nat Rev Drug Discov. 2017;16(7):472–486. https://doi.org/10.1038/nrd.2017.16.; Algamal M, Saltiel N, Pearson AJ, Ager B, Burca I, Mouzon B et al. Impact of Repetitive Mild Traumatic Brain Injury on Behavioral and Hippocampal Deficits in a Mouse Model of Chronic Stress. J Neurotrauma. 2019;36(17):2590–2607. https://doi.org/10.1089/neu.2018.6314.; Huang RR, Hu W, Yin YY, Wang YC, Li WP, Li WZ. Chronic restraint stress promotes learning and memory impairment due to enhanced neuronal endoplasmic reticulum stress in the frontal cortex and hippocampus in male mice. Int J Mol Med. 2015;35(2):553–559. https://doi.org/10.3892/ijmm.2014.2026.; Musey PI Jr, Schultebraucks K, Chang BP. Stressing Out About the Heart: A Narrative Review of the Role of Psychological Stress in Acute Cardiovascular Events. Acad Emerg Med. 2020;27(1):71–79. https://doi.org/10.1111/acem.13882.; Austin AW, Wissmann T, von Kanel R. Stress and hemostasis: an update. Semin Thromb Hemost. 2013;39(8):902–912. https://doi.org/10.1055/s-0033-1357487.; von Känel R. Acute mental stress and hemostasis: When physiology becomes vascular harm. Thromb Res. 2015;135(Suppl 1):S52–S55. https://doi.org/10.1016/S0049-3848(15)50444-1.; Orr E, Arbel T, Levy M, Sela Y, Weissberger O, Liran O, Lewis J. Virtual reality in the management of stress and anxiety disorders: A retrospective analysis of 61 people treated in the metaverse. Heliyon. 2023;9(7):e17870. https://doi.org/10.1016/j.heliyon.2023.e17870.; Шишкова ВН. Простые и эффективные решения в коррекции тревоги и стресса. Медицинский совет. 2023;17(3):161–167. https://doi.org/10.21518/ms2023-023.; Кабакова ТИ, Андреева НА, Попова ЕА. Результаты социологического опроса потребителей седативных препаратов безрецептурного отпуска. Фундаментальные исследования. 2011;(11-1):202–207. Режим доступа: https://elibrary.ru/oigmlx.; Конарева ИН. Влияние седативных препаратов растительного происхождения на эмоциональную сферу человека. Ученые записки Таврического национального университета им. В.И. Вернадского. Серия «Биология, химия». 2009;22(2):67–71. Режим доступа: https://cyberleninka.ru/article/n/vliyanie-sedativnyh-preparatov-rastitelnogo-proishozhdeniya-na-emotsionalnuyu-sferu-cheloveka?ysclid=loy2zbrph2337232891.; Mineo L, Concerto C, Patel D, Mayorga T, Paula M, Chusid E et al. Valeriana officinalis Root Extract Modulates Cortical Excitatory Circuits in Humans. Neuropsychobiology. 2017;75(1):46–51. https://doi.org/10.1159/000480053.; Морохина СЛ, Аляутдин РН, Каперко ДА, Шубникова ЕВ, Снегирева ИИ, Смирнова ЮА. Нежелательные реакции при применении препаратов валерианы и корвалола: анализ спонтанных сообщений. Безопасность и риск фармакотерапии. 2018;6(4):162–173. https://doi.org/10.30895/2312-7821-2018-6-4-162-173.; Patočka J, Jakl J. Biomedically relevant chemical constituents of Valeriana officinalis. J Appl Biomed. 2010;8(1):11–18. https://doi.org/10.2478/v10136-009-0002-z.; Кароматов ИД, Рахматова ДИ. Валериана лекарственная и перспективы применения в неврологической и общеврачебной практике (литературный обзор). Биология и интегративная медицина. 2016;(1):91–108. Режим доступа: https://cyberleninka.ru/article/n/valeriana-lekarstvennaya-i-perspektivy-primeneniya-v-nevrologicheskoy-i-obschevrachebnoy-praktike-literaturnyy-obzor?ysclid=loy5gh57ft443838497.; Khatkar S, Lather A, Khatkar A. Valerenic and acetoxyvalerenic acid. In: Belwal T, Nabavi SM, Nabavi SF, Dehpour AR, Shirooie S (eds). Naturally Occurring Chemicals Against Alzheimer’s Disease. Elsevier Inc.; 2021. Р. 117– 125. https://doi.org/10.1016/B978-0-12-819212-2.00045-1.; Dietz BM, Mahady GB, Pauli GF, Farnsworth NR. Valerian extract and valerenic acid are partial agonists of the 5-HT5a receptor in vitro. Brain Res Mol Brain Res. 2005;138(2):191–197. https://doi.org/10.1016/j.molbrainres.2005.04.009.; Корабельникова ЕА, Данилов АБ. Применение препаратов лекарственных трав для лечения инсомнии. Медицинский алфавит. 2019;2(19):11–18. https://doi.org/10.33667/2078-5631-2019-2-19(394)-11-18; Пояркова НМ, Чулкова ВВ, Сапарклычева СЕ. Мята перечная (Mentha piperitaL.) – важнейшее эфирномасличное растение. Вестник биотехнологии. 2020;(1):12. Режим доступа: https://bio.urgau.ru/ru/1-22-2020/12-01-2020.; Соловьева НА, Юсупова МЗ. Применение эфиромасличной продукции в медицине на примере подсолнечника однолетнего и мяты перечной. В: Богатырев СА (ред.). Безопасность и качество товаров: материалы XIV Международной научно-практической конференции. Саратов, 16 июля 2020 г. Саратов: Саратовский государственный аграрный университет им. Н.И. Вавилова; 2020. 242 с. Режим доступа: https://elibrary.ru/nyukoo.; Хажжар Ф, Потанина ОГ. Обоснованность выбора состава комбинированного растительного лекарственного средства седативного действия. В: Гуленков АС, Борисенко ЕВ. 90 лет – от растения до лекарственного препарата: достижения и перспективы: сборник материалов юбилейной международной научной конференции. Москва, 10–11 июня 2021 г. М.: ФГБУ «Всероссийский научно-исследовательский институт лекарственных и ароматических растений»; 2021. 613 с. Режим доступа: https://repository.rudn.ru/ru/records/article/record/78739/.; Девликамова ФИ, Хайбуллина ДХ, Максимов ЮН, Кадырова ЛР. Тревожные расстройства в общеклинической практике. Медицинский совет. 2023;17(6):95–102. https://doi.org/10.21518/ms2023-094.; Shikov AN, Pozharitskaya ON, Makarov VG, Demchenko DV, Shikh EV. Effect of Leonurus cardiaca oil extract in patients with arterial hypertension accompanied by anxiety and sleep disorders. Phytother Res. 2011;25(4):540–543. https://doi.org/10.1002/ptr.3292.; Морозова МА, Пельтихина ОВ, Морозов АМ. Применение фитотерапевтических средств в лечении заболеваний сердечно-сосудистой системы. Синергия наук. 2018;(S24):51–59. Режим доступа: https://elibrary.ru/xtakfn.; https://www.med-sovet.pro/jour/article/view/7937

الاتاحة: https://www.med-sovet.pro/jour/article/view/7937
https://doi.org/10.21518/ms2023-432

View record in BASE

11

Academic Journal

Insomnia and anxiety in older adults ; Бессонница и тревога у пожилых

المؤلفون: N. V. Pizova, A. V. Pizov, Н. В. Пизова, А. В. Пизов

المصدر: Meditsinskiy sovet = Medical Council; № 10 (2023); 98-105 ; Медицинский Совет; № 10 (2023); 98-105 ; 2658-5790 ; 2079-701X

مصطلحات موضوعية: γ-аминомасляная кислота, anxiety, insomnia, comorbidity, therapeutic approaches, γ-aminobutyric acid, тревога, бессонница, коморбидность, терапевтические подходы

وصف الملف: application/pdf

Relation: https://www.med-sovet.pro/jour/article/view/7646/6779; Babazadeh T., Sarkhoshi R., Bahadori F., Moradi F., Shariat F., Sherizadeh Y. Prevalence of depression, anxiety and stress disorders in elderly people residing in Khoy, Iran (2014–2015). J Res Clin Med. 2016;4(2):122–128. https://doi.org/10.15171/jarcm.2016.020.; Liu X., Liu F., Ruan W., Chen Y., Qu S., Wang W. Mental health status and associated contributing factors among the Hakka elderly in Fujian, China. Front Public Health. 2022;10:928880. https://doi.org/10.3389/fpubh.2022.928880.; Abdul Manaf M.R., Mustafa M., Abdul Rahman M.R., Yusof K.H., Abd Aziz N.A. Factors Influencing the Prevalence of Mental Health Problems among Malay Elderly Residing in a Rural Community: A Cross- Sectional Study. PLoS ONE. 2016;11(6):e0156937. https://doi.org/10.1371/journal.pone.0156937.; Hosseini F.S., Sharifi N., Jamali S. Correlation anxiety, stress, and depression with perceived social support among the elderly: a cross-s ectional study in Iran. Ageing Int. 2021;46(1):108–114. https://doi.org/10.1007/s12126-020-09376-9.; Baglioni C., Battagliese G., Feige B., Spiegelhalder K., Nissen C., Voderholzer U. et al. Insomnia as a predictor of depression: a meta-analytic evaluation of longitudinal epidemiological studies. J Affect Disord. 2011;135(1-3):10–19. https://doi.org/10.1016/j.jad.2011.01.011.; Pigeon W.R., Bishop T.M., Krueger K.M. Insomnia as a Precipitating Factor in New Onset Mental Illness: a Systematic Review of Recent Findings. Curr Psychiatry Rep. 2017;19(8):44. https://doi.org/10.1007/s11920-017-0802-x.; Brenes G.A., Miller M.E., Stanley M.A., Williamson J.D., Knudson M., McCall W.V. Insomnia in older adults with generalized anxiety disorder. Am J Geriatr Psychiatry. 2009;17(6):465–472. https://doi.org/10.1097/jgp.0b013e3181987747.; Crowley K. Sleep and sleep disorders in older adults. Neuropsychol Rev. 2011;21(1):41–53. https://doi.org/10.1007/s11065-010-9154-6.; El- Gabalawy R., Mackenzie C.S., Thibodeau M.A., Asmundson G.J., Sareen J. Health anxiety disorders in older adults: conceptualizing complex conditions in late life. Clin Psychol Rev. 2013;33(8):1096–1105. https://doi.org/10.1016/j.cpr.2013.08.010.; Wolitzky- Taylor K.B., Castriotta N., Lenze E.J., Stanley M.A., Craske M.G. Anxiety disorders in older adults: a comprehensive review. Depress Anxiety. 2010;27(2):190–211. https://doi.org/10.1002/da.20653.; Mutepfa M.M., Motsamai T.B., Wright T.C., Tapera R., Kenosi L.I. Anxiety and somatization: prevalence and correlates of mental health in older people (60+ years) in Botswana. Aging Ment Health. 2021;25(12):2320–2329. https://doi.org/10.1080/13607863.2020.1822289.; Ahmed D., El Shair I.H., Taher E., Zyada F. Prevalence and predictors of depression and anxiety among the elderly population living in geriatric homes in Cairo, Egypt. J Egypt Public Health Assoc. 2014;89(3):127–135. https://doi.org/10.1097/01.EPX.0000455729.66131.49.; Cho S.M., Saw Y.M., Saw T.N., Than T.M., Khaing M., Khine A.T. et al. Prevalence and risk factors of anxiety and depression among the community- dwelling elderly in Nay Pyi Taw Union Territory, Myanmar. Sci Rep. 2021;11(1):9763. https://doi.org/10.1038/s41598-021-88621-w.; Andreas S., Schulz H., Volkert J., Dehoust M., Sehner S., Suling A. et al. Prevalence of mental disorders in elderly people: the European MentDis_ ICF65+ study. Br J Psychiatry. 2017;210(2):125–131. https://doi.org/10.1192/bjp.bp.115.180463.; Raeisvandi A., Amerzadeh M., Hajiabadi F., Hosseinkhani Z. Prevalence and the affecting factors on depression, anxiety and stress (DASS) among elders in Qazvin City, in the Northwest of Iran. BMC Geriatr. 2023;23(1):202. https://doi.org/10.1186/s12877-023-03908-z.; Thapa D.K., Visentin D.C., Kornhaber R., Cleary M. Prevalence and factors associated with depression, anxiety, and stress symptoms among older adults: A cross- sectional population- based study. Nurs Health Sci. 2020;22(4):1139–1152. https://doi.org/10.1111/nhs.12783.; Amu H., Osei E., Kofie P., Owusu R., Bosoka S.A., Konlan K.D. et al. Prevalence and predictors of depression, anxiety, and stress among adults in Ghana: A community- based cross- sectional study. PLoS ONE. 2021;16(10):e0258105. https://doi.org/10.1371/journal.pone.0258105.; Monroe D.C., McDowell C.P., Kenny R.A., Herring M.P. Dynamic associations between anxiety, depression, and tobacco use in older adults: Results from The Irish Longitudinal Study on Ageing. J Psychiatr Res. 2021;139:99–105. https://doi.org/10.1016/j.jpsychires.2021.05.017.; McDowell C.P., Gordon B.R., Andrews K.L., MacDonncha C., Herring M.P. Associations of physical activity with anxiety symptoms and status: results from The Irish longitudinal study on ageing. Epidemiol Psychiatr Sci. 2019;28(4):436–445. https://doi.org/10.1017/S204579601800001X.; Kogan J.N., Edelstein B.A., McKee D.R. Assessment of anxiety in older adults: current status. J Anxiety Disord. 2000;14(2):109–132. https://doi.org/10.1016/s0887-6185(99)00044-4.; Seignourel P.J., Kunik M.E., Snow L., Wilson N., Stanley M. Anxiety in dementia: a critical review. Clin Psychol Rev. 2008;28(7):1071–1082. https://doi.org/10.1016/j.cpr.2008.02.008.; Therrien Z., Hunsley J. Assessment of anxiety in older adults: a systematic review of commonly used measures. Aging Ment Health. 2012;16(1):1–16. https://doi.org/10.1080/13607863.2011.602960.; Cully J.A., Graham D.P., Stanley M.A., Ferguson C.J., Sharafkhaneh A., Souchek J., Kunik M.E. Quality of life in patients with chronic obstructive pulmonary disease and comorbid anxiety or depression. Psychosomatics. 2006;47(4):312–319. https://doi.org/10.1176/appi.psy.47.4.312.; Naughton C., Feely J., Bennett K. A clustered randomized trial of the effects of feedback using academic detailing compared to postal bulletin on prescribing of preventative cardiovascular therapy. Fam Pract. 2007;24(5):475–480. https://doi.org/10.1093/fampra/cmm044.; Bryant C., Mohlman J., Gum A., Stanley M., Beekman A.T., Wetherell J.L. et al. Anxiety disorders in older adults: looking to DSM5 and beyond. Am J Geriatr Psychiatry. 2013;21(9):872–876. https://doi.org/10.1016/j.jagp.2013.01.011.; Hellwig S., Domschke K. Anxiety in Late Life: An Update on Pathomechanisms. Gerontology. 2019;65(5):465–473. https://doi.org/10.1159/000500306.; Xie Q., Xu Y.M., Zhong B.L. Anxiety symptoms in older Chinese adults in primary care settings: Prevalence and correlates. Front Public Health. 2022;10:1009226. https://doi.org/10.3389/fpubh.2022.1009226.; Dopheide J.A. Insomnia overview: epidemiology, pathophysiology, diagnosis and monitoring, and nonpharmacologic therapy. Am J Manag Care. 2020;26(4 Suppl.):S76–S84. https://doi.org/10.37765/ajmc.2020.42769.; McCall W.V. Sleep in the Elderly: Burden, Diagnosis, and Treatment. Prim Care Companion J Clin Psychiatry. 2004;6(1):9–20. https://doi.org/10.4088/pcc.v06n0104.; Xu Y.M., Li C., Zhu R., Zhong B.L. Prevalence and Correlates of Insomnia Symptoms in Older Chinese Adults During the COVID- 19 Outbreak: A Classification Tree Analysis. J Geriatr Psychiatry Neurol. 2022;35(2):223–228. https://doi.org/10.1177/08919887221078561.; Cao X.L., Wang S.B., Zhong B.L., Zhang L., Ungvari G.S., Ng C.H. et al. The prevalence of insomnia in the general population in China: A meta-analysis. PLoS ONE. 2017;12(2):e0170772. https://doi.org/10.1371/journal.pone.0170772.; Wang W., Shi H., Jia H., Sun J., Li L., Yang Y. et al. A cross- sectional study of current status and risk factors of insomnia among adult residents in Hebei province. Chin Ment Health J. 2021;35(06):455–460. https://doi.org/10.3969/j.issn.1000-6729.2021.06.003.; Xu H., Huang L., Sheng Y. Investigation of the status quo of insomnia in visiting residents of a community in Shanghai. Shanghai Med Pharmaceutic J. 2019;40:45–47. https://doi.org/10.3969/j.issn.1006-1533.2019.18.014.; Hohagen F., Käppler C., Schramm E., Rink K., Weyerer S., Riemann D., Berger M. Prevalence of insomnia in elderly general practice attenders and the current treatment modalities. Acta Psychiatr Scand. 1994;90(2):102–108. https://doi.org/10.1111/j.1600-0447.1994.tb01563.x.; Dahale A.B., Jaisoorya T.S., Manoj L., Kumar G.S., Gokul G.R., Radhakrishnan R. et al. Insomnia among elderly primary care patients in India. Prim Care Companion CNS Disord. 2020;22(3):19m02581. https://doi.org/10.4088/PCC.19m02581.; Proserpio P., Biggio G., Ferri R., Girardi P., Agostoni E.C., Manni R. et al. Insomnia in primary care: a survey conducted on Italian patients older than 50 years- results from the “Sonno e Salute” study. Neurol Sci. 2022;43(11):6487–6494. https://doi.org/10.1007/s10072-022-06309-z.; Sateia M.J. International classification of sleep disorders-t hird edition. Chest. 2014;146(5):1387–1394. https://doi.org/10.1378/chest.14-0970.; Buysse D.J. Insomnia. JAMA. 2013;309(7):706–716. https://doi.org/10.1001/jama.2013.193.; Foley D.J., Monjan A.A., Brown S.L., Simonsick E.M., Wallace R.B., Blazer D.G. Sleep complaints among older persons: an epidemiological study of three communities. Sleep. 1995;18(6):425–432. https://doi.org/10.1093/sleep/18.6.425.; Stewart N.H., Arora V.M. Sleep in Hospitalized Older Adults. Sleep Med Clin. 2018;13(1):127–135. https://doi.org/10.1016/j.jsmc.2017.09.012.; Campbell S.S., Murphy P.J. The nature of spontaneous sleep across adulthood. J Sleep Res. 2007;16(1):24–32. https://doi.org/10.1111/j.1365-2869.2007.00567.x.; Dorffner G., Vitr M., Anderer P. The effects of aging on sleep architecture in healthy subjects. In: Vlamos P., Alexiou A. (eds.). GeNeDis 2014. Advances in Experimental Medicine and Biology. Springer, Cham; 2015. Vol. 821, pp. 93–100. https://doi.org/10.1007/978-3-319-08939-3_13.; Ohayon M.M., Carskadon M.A., Guilleminault C., Vitiello M.V. Meta-analysis of quantitative sleep parameters from childhood to old age in healthy individuals: developing normative sleep values across the human lifespan. Sleep. 2004;27(7):1255–1273. https://doi.org/10.1093/sleep/27.7.1255.; Floyd J.A., Janisse J.J., Jenuwine E.S., Ager J.W. Changes in REM-sleep percentage over the adult lifespan. Sleep. 2007;30(7):829. https://doi.org/10.1093/sleep/30.7.829.; Fang W., Li Z., Wu L., Cao Z., Liang Y., Yang H. et al. Longer habitual afternoon napping is associated with a higher risk for impaired fasting plasma glucose and diabetes mellitus in older adults: results from the Dongfeng- Tongji cohort of retired workers. Sleep Med. 2013;14(10):950–954. https://doi.org/10.1016/j.sleep.2013.04.015.; Furihata R., Kaneita Y., Jike M., Ohida T., Uchiyama M. Napping and associated factors: a Japanese nationwide general population survey. Sleep Med. 2016;20:72–79. https://doi.org/10.1016/j.sleep.2015.12.006.; Milner C.E., Cote K.A. Benefits of napping in healthy adults: impact of nap length, time of day, age, and experience with napping. J Sleep Res. 2009;18(2):272–281. https://doi.org/10.1111/j.1365-2869.2008.00718.x.; Ficca G., Axelsson J., Mollicone D.J., Muto V., Vitiello M.V. Naps, cognition and performance. Sleep Med Rev. 2010;14(4):249–258. https://doi.org/10.1016/j.smrv.2009.09.005.; Пизова Н.В. Инсомния у лиц пожилого возраста. Медицинский совет. 2016;(17):34–37. https://doi.org/10.21518/2079-701X-2016-17-34-37.; Александровский Ю.А., Вейн А.М. Расстройства сна. СПб.: МИА; 1995. 160 с. Режим доступа: https://booksmed.info/psixiatriya-psixologiya/2624-rasstroystva-sna-aleksandrovskiy.html.; Morin C.M., Jarrin D.C. Epidemiology of Insomnia: Prevalence, Course, Risk Factors, and Public Health Burden. Sleep Med Clin. 2022;17(2):173–191. https://doi.org/10.1016/j.jsmc.2022.03.003; Yang J.J., Cai H., Xia L., Nie W., Zhang Y., Wang S. et al. The prevalence of depressive and insomnia symptoms, and their association with quality of life among older adults in rural areas in China. Front Psychiatr. 2021;12:727939. https://doi.org/10.3389/fpsyt.2021.727939.; Zeng L.N., Zong Q.Q., Yang Y., Zhang L., Xiang Y.F., Ng C.H. et al. Gender Difference in the Prevalence of Insomnia: A Meta-A nalysis of Observational Studies. Front Psychiatry. 2020;11:577429. https://doi.org/10.3389/fpsyt.2020.577429.; Brewster G.S., Riegel B., Gehrman P.R. Insomnia in the Older Adult. Sleep Med Clin. 2022;17(2):233–239. https://doi.org/10.1016/j.jsmc.2022.03.004.; Bhaskar S., Hemavathy D., Prasad S. Prevalence of chronic insomnia in adult patients and its correlation with medical comorbidities. J Family Med Prim Care. 2016;5(4):780–784. https://doi.org/10.4103/2249-4863.201153.; Taylor D.J., Mallory L.J., Lichstein K.L., Durrence H.H., Riedel B.W., Bush A.J. Comorbidity of chronic insomnia with medical problems. Sleep. 2007;30(2):213–218. https://doi.org/10.1093/sleep/30.2.213.; Louie G.H., Tektonidou M.G., Caban- Martinez A.J., Ward M.M. Sleep disturbances in adults with arthritis: prevalence, mediators, and subgroups at greatest risk. Data from the 2007 National Health Interview Survey. Arthritis Care Res (Hoboken). 2011;63(2):247–260. https://doi.org/10.1002/acr.20362.; Zhong B.L., Li H.J., Xu Y.M., Jiang X.F. Clinical insomnia among elderly primary care attenders in Wuhan, China: A multicenter cross- sectional epidemiological study. Front Public Health. 2022;10:1026034. https://doi.org/10.3389/fpubh.2022.1026034.; Li J., Yang B., Varrasse M., Li K. Sleep Among Long- Term Care Residents in China: A Narrative Review of Literature. Clin Nurs Res. 2018;27(1):35–60. https://doi.org/10.1177/1054773816673175.; Zantinge E.M., van den Berg M., Smit H.A., Picavet H.S. Retirement and a healthy lifestyle: opportunity or pitfall? A narrative review of the literature. Eur J Public Health. 2014;24(3):433–439. https://doi.org/10.1093/eurpub/ckt157.; Li J., Vitiello M.V., Gooneratne N.S. Sleep in Normal Aging. Sleep Med Clin. 2018;13(1):1–11. https://doi.org/10.1016/j.jsmc.2017.09.001.; Salive M.E. Multimorbidity in older adults. Epidemiol Rev. 2013;35(1):75–83. https://doi.org/10.1093/epirev/mxs009.; Kaufman D.W., Kelly J.P., Rosenberg L., Anderson T.E., Mitchell A.A. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA. 2002;287(3):337–344. https://doi.org/10.1001/jama.287.3.337.; Linjakumpu T., Hartikainen S., Klaukka T., Veijola J., Kivelä S.L., Isoaho R. Use of medications and polypharmacy are increasing among the elderly. J Clin Epidemiol. 2002;55(8):809–817. https://doi.org/10.1016/s08954356(02)00411-0.; Boockvar K.S. Reducing sedative- hypnotic medication use in older adults with sleep problems. Clin Ther. 2016;38(11):2330–2331. https://doi.org/10.1016/j.clinthera.2016.10.003.; Sutton E.L. Psychiatric disorders and sleep issues. Med Clin. 2014;98(5):1123–1143. https://doi.org/10.1016/j.mcna.2014.06.009.; Ferre Navarrete F., Pérez Páramo M., Fermin Ordoño J., López Gómez V. Prevalence of Insomnia and Associated Factors in Outpatients With Generalized Anxiety Disorder Treated in Psychiatric Clinics. Behav Sleep Med. 2017;15(6):491–501. https://doi.org/10.1080/15402002.2016.1163703.; Marcks B.A., Weisberg R.B., Edelen M.O., Keller M.B. The relationship between sleep disturbance and the course of anxiety disorders in primary care patients. Psychiatry Res. 2010;178(3):487–492. https://doi.org/10.1016/j.psychres.2009.07.004.; Potvin O., Lorrain D., Belleville G., Grenier S., Préville M. Subjective sleep characteristics associated with anxiety and depression in older adults: a population- based study. Int J Geriatr Psychiatry. 2014;29(12):1262–1270. https://doi.org/10.1002/gps.4106.; Jansson- Fröjmark M., Lindblom K. A bidirectional relationship between anxiety and depression, and insomnia? A prospective study in the general population. J Psychosom Res. 2008;64(4):443–449. https://doi.org/10.1016/j.jpsychores.2007.10.016.; Kennair L.E.O., Hagen R., Hjemdal O., Havnen A., Ryum T., Solem S. Depression, Anxiety, Insomnia, and Quality of Life in a Representative Community Sample of Older Adults Living at Home. Front Psychol. 2022;13:811082. https://doi.org/10.3389/fpsyg.2022.811082.; Yu B., Steptoe A., Niu K., Ku P.W., Chen L.J. Prospective associations of social isolation and loneliness with poor sleep quality in older adults. Qual Life Res. 2018;27(3):683–691. https://doi.org/10.1007/s11136-017-1752-9.; Belleville G., Cousineau H., Levrier K., St- Pierre- Delorme M.È. Meta-analytic review of the impact of cognitive-behavior therapy for insomnia on concomitant anxiety. Clin Psychol Rev. 2011;31(4):638–652. https://doi.org/10.1016/j.cpr.2011.02.004.; Kessler R.C., Berglund P.A., Coulouvrat C., Fitzgerald T., Hajak G., Roth T. et al. Insomnia, comorbidity, and risk of injury among insured americans: results from the america insomnia survey. Sleep. 2012;35(6):825–834. https://doi.org/10.5665/sleep.1884.; Mellman T.A. Sleep and anxiety disorders. Psychiatr Clin North Am. 2006;29(4):1047-x. https://doi.org/10.1016/j.psc.2006.08.005.; Chiao Y.W., Livneh H., Guo H.R., Chen W.J., Lu M.C., Lin M.C. et al. Use of Chinese Herbal Medicines Is Related to a Reduction in Depression Risk Among Patients With Insomnia: A Matched Cohort Study. Front Neurol. 2021;11:583485. https://doi.org/10.3389/fneur.2020.583485.; Taylor D.J., Lichstein K.L., Durrence H.H., Reidel B.W., Bush A.J. Epidemiology of insomnia, depression, and anxiety. Sleep. 2005;28(11):1457–1464. https://doi.org/10.1093/sleep/28.11.1457.; Gebara M.A., Siripong N., DiNapoli E.A., Maree R.D., Germain A., Reynolds C.F. et al. Effect of insomnia treatments on depression: A systematic review and meta-analysis. Depress Anxiety. 2018;35(8):717–731. https://doi.org/10.1002/da.22776.; Ye Y.Y., Zhang Y.F., Chen J., Liu J., Li X.J., Liu Y.Z. et al. Internet- Based Cognitive Behavioral Therapy for Insomnia (ICBT-i) Improves Comorbid Anxiety and Depression- A Meta- Analysis of Randomized Controlled Trials. PLoS ONE. 2015;10(11):e0142258. https://doi.org/10.1371/journal.pone.0142258.; Riemann D., Baglioni C., Bassetti C., Bjorvatn B., Dolenc Groselj L., Ellis J.G. et al. European guideline for the diagnosis and treatment of insomnia. J Sleep Res. 2017;26(6):675–700. https://doi.org/10.1111/jsr.12594.; Соколова Л.П. Нарушения сна и бодрствования: клинические проявления и направления терапии. Нервные болезни. 2021;(2):54–63. https://doi.org/10.24412/2226-0757-2021-12325. Sokolova L.P. Sleep-wake disorders: clinical manifestations and aspects of therapy. Nervous Diseases. 2021;(2):54–63. (In Russ.) https://doi.org/10.24412/2226-0757-2021-12325.; Baldwin D.S., Waldman S., Allgulander C. Evidence-b ased pharmacological treatment of generalized anxiety disorder. Int J Neuropsychopharmacol. 2011;14(5):697–710. https://doi.org/10.1017/S1461145710001434.; Чутко Л.С., Сурушкина С.Ю. Тревожный пациент на приеме у невролога. РМЖ. Медицинское обозрение. 2020;4(9):590–594. https://doi.org/10.32364/2587-6821-2020-4-9-590-594.; Takaesu Y., Komada Y., Asaoka S., Kagimura T., Inoue Y. Factors associated with long-term use of hypnotics among patients with chronic insomnia. PLoS ONE. 2014;9(11):e113753. https://doi.org/10.1371/journal.pone.0113753.; Калуев А.В., Натт Д.Д. О роли ГАМК в патогенезе тревоги и депрессии. Экспериментальная и клиническая фармакология. 2004;67(4):71–76. Режим доступа: http://www.ekf.folium.ru/index.php/ekf/article/view/1313.; Naureen Z., Dhuli K., Medori M.C., Caruso P., Manganotti P., Chiurazzi P., Bertelli M. Dietary supplements in neurological diseases and brain aging. J Prev Med Hyg. 2022;63(2 Suppl.):E174–E188. https://doi.org/10.15167/2421-4248/jpmh2022.63.2S3.2759.; Chuang C.Y., Shi Y.C., You H.P., Lo Y.H., Pan T.M. Antidepressant effect of GABA-rich monascus- fermented product on forced swimming rat model. J Agric Food Chem. 2011;59(7):3027–3034. https://doi.org/10.1021/jf104239m.; Yamatsu A., Yamashita Y., Pandharipande T., Maru I., Kim M. Effect of oral γ-aminobutyric acid (GABA) administration on sleep and its absorption in humans. Food Sci Biotechnol. 2016;25(2):547–551. https://doi.org/10.1007/s10068-016-0076-9.; Kim S., Jo K., Hong K.B., Han S.H., Suh H.J. GABA and l-theanine mixture decreases sleep latency and improves NREM sleep. Pharm Biol. 2019;57(1):65–73. https://doi.org/10.1080/13880209.2018.1557698.; Zheng K.H., Khan A., Espiridion E.D. Phenibut Addiction in a Patient with Substance Use Disorder. Cureus. 2019;11(7):e5230. https://doi.org/10.7759/cureus.5230.; Яковлев Е.В., Леонтьев О.В. Оценка эффективности транквилоноотропной терапии в комплексном лечении неврозов с головной болью. Вестник психотерапии. 2018;(67):33–43. Режим доступа: https://www.elibrary.ru/item.asp?id=35668481&ysclid=ljeersvkv0678336214.; Rasmussen M.K., Mestre H., Nedergaard M. The glymphatic pathway in neurological disorders. Lancet Neurol. 2018;17(11):1016–1024. https://doi.org/10.1016/s1474-4422(18)30318-1.; Есин Р.Г., Есин О.Р., Хакимова А.Р. Стресс- индуцированные расстройства. Журнал неврологии и психиатрии им. С.С. Корсакова. 2020;120(5):131–137. https://doi.org/10.17116/jnevro2020120051131.; Есин О.Р., Хайруллин И.Х., Есин Р.Г., Токарева Н.В. Головная боль напряжения: эффективность ГАМКергического препарата анвифен. Журнал неврологии и психиатрии им. C.C. Корсакова. 2016;116(2):58–61. https://doi.org/10.17116/jnevro20161162158-61.; Есин Р.Г., Хайруллин И.Х., Есин О.Р., Малова Л.А., Алимбекова Л.Р. Эффективность препарата Анвифен при лечении пациентов с синдромом постковидного «тумана в голове». Журнал неврологии и психиатрии им. С.С. Корсакова. 2022;122(8):101–105. https://doi.org/10.17116/jnevro2022122081101.; Дума С.Н. Роль коррекции психовегетативного синдрома в лечении пациентов с головной болью напряжения. Журнал неврологии и психиатрии им. C.C. Корсакова. 2015;115(2):68–70. https://doi.org/10.17116/ jnevro20151152168-70.; Котова О.В., Замерград М.В. Головокружение и тревожные расстройства у лиц пожилого возраста. Терапевтический архив. 2016;88(9):131–134. https://doi.org/10.17116/terarkh2016889131-134.; Есин О.Р., Хайруллин И.Х., Есин Р.Г., Малова Л.А. Эффективность короткого и пролонгированного курсового лечения тревожного расстройства препаратом Анвифен. Журнал неврологии и психиатрии им. С.С. Корсакова. 2022;122(12):68–73. https://doi.org/10.17116/jnevro202212212168.; https://www.med-sovet.pro/jour/article/view/7646

الاتاحة: https://www.med-sovet.pro/jour/article/view/7646
https://doi.org/10.21518/ms2023-226

View record in BASE

12

Academic Journal

Peculiarities of insomnia in men and women at different age periods ; Особенности бессонницы у мужчин и женщин в разные возрастные периоды

المؤلفون: N. V. Pizova, A. V. Pizov, Н. В. Пизова, А. В. Пизов

المصدر: Meditsinskiy sovet = Medical Council; № 21 (2022); 112-118 ; Медицинский Совет; № 21 (2022); 112-118 ; 2658-5790 ; 2079-701X

مصطلحات موضوعية: мелатонин, sleep disorders, gender and age peculiarities, therapy, melatonin, нарушения сна, половозрастные особенности, терапия

وصف الملف: application/pdf

Relation: https://www.med-sovet.pro/jour/article/view/7211/6466; Kessler R.C., Berglund P.A., Coulouvrat C., Hajak G., Roth T., Shahly V. et al. Insomnia and the performance of US workers: results from the America insomnia survey. Sleep. 2011;34(9):1161–1171. https://doi.org/10.5665/sleep.1230.; Gencarelli A., Sorrell A., Everhart C.M., Zurlinden T., Everhart D.E. Behavioral and exercise interventions for sleep dysfunction in the elderly: a brief review and future directions. Sleep Breath. 2021;25(4):2111–2118. https://doi.org/10.1007/s11325-021-02329-9.; Chattu V.K., Gholizadeh M., Shapiro C.M. Estimation of costs and cost-effectiveness of detecting undiagnosed sleep disorders among chronic disease patients: a typical gp setting in Toronto. Sleep Med. 2019;64(1):S345–S346. https://doi.org/10.1016/j.sleep.2019.11.964.; De Mello M.T., Narciso F.V., Tufik S., Paiva T., Spence D.W., Bahammam A.S. et al. Sleep disorders as a cause of motor vehicle collisions. Int J Prev Med. 2013;4(3):246–257. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3634162/.; Patel D., Steinberg J., Patel P. Insomnia in the Elderly: A Review. J Clin Sleep Med. 2018;14(6):1017–1024. https://doi.org/10.5664/jcsm.7172.; Spielman A.J., Caruso L.S., Glovinsky P.B. A behavioral perspective on insomnia treatment. Psychiatr Clin North Am. 1987;10(4):541–553. https://doi.org/10.1016/S0193-953X(18)30532-X.; Ohayon M.M. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev. 2002;6(2):97–111. https://doi.org/10.1053/smrv.2002.0186.; Patel N.P., Grandner M.A., Xie D., Branas C.C., Gooneratne N. “Sleep disparity” in the population: poor sleep quality is strongly associated with poverty and ethnicity. BMC Public Health. 2010;10:475. https://doi.org/10.1186/1471-2458-10-475.; Morgan K. Daytime activity and risk factors for late-life insomnia. J Sleep Res. 2003;12(3):231–238. https://doi.org/10.1046/j.1365-2869.2003.00355.x.; Foley D.J., Monjan A., Simonsick E.M., Wallace R.B., Blazer D.G. Incidence and remission of insomnia among elderly adults: an epidemiologic study of 6,800 persons over three years. Sleep. 1999;22(Suppl. 2):S366–372. Available at: https://pubmed.ncbi.nlm.nih.gov/10394609/.; Foley D.J., Monjan A.A., Izmirlian G., Hays J.C., Blazer D.G. Incidence and remission of insomnia among elderly adults in a biracial cohort. Sleep. 1999;22(Suppl. 2):S373–378. Available at: https://pubmed.ncbi.nlm.nih.gov/10394610/.; Brenes G.A., Miller M.E., Stanley M.A., Williamson J.D., Knudson M., McCall W.V. Insomnia in older adults with generalized anxiety disorder. Am J Geriatr Psychiatry. 2009;17(6):465–472. https://doi.org/10.1097/jgp.0b013e3181987747.; Roth T., Coulouvrat C., Hajak G., Lakoma M.D., Sampson N.A., Shahly V. et al. Prevalence and perceived health associated with insomnia based on DSM-IV-TR; International Statistical Classification of Diseases and Related Health Problems, Tenth Revision; and Research Diagnostic Criteria/International Classification of Sleep Disorders, Second Edition criteria: results from the America Insomnia Survey. Biol Psychiatry. 2011;69(6):592–600. https://doi.org/10.1016/j.biopsych.2010.10.023.; Walsh J.K., Coulouvrat C., Hajak G., Lakoma M.D., Petukhova M., Roth T. et al. Nighttime insomnia symptoms and perceived health in the America Insomnia Survey (AIS). Sleep. 2011;34(8):997–1011. https://doi.org/10.5665/SLEEP.1150.; Zhang B., Wing Y.K. Sex differences in insomnia: a meta-analysis. Sleep. 2006;29(1):85–93. https://doi.org/10.1093/sleep/29.1.85.; Kische H., Ewert R., Fietze I., Gross S., Wallaschofski H., Völzke H. et al. Sex Hormones and Sleep in Men and Women From the General Population: A Cross-Sectional Observational Study. J Clin Endocrinol Metab. 2016;101(11):3968–3977. https://doi.org/10.1210/jc.2016-1832.; Calhoun S.L., Fernandez-Mendoza J., Vgontzas A.N., Liao D., Bixler E.O. Prevalence of insomnia symptoms in a general population sample of young children and preadolescents: gender effects. Sleep Med. 2014;15(1):91–95. https://doi.org/10.1016/j.sleep.2013.08.787.; Kızılırmak A., Timur S., Kartal B. Insomnia in pregnancy and factors related to insomnia. ScientificWorldJournal. 2012:197093. https://doi.org/10.1100/2012/197093.; Kravitz H.M., Ganz P.A., Bromberger J., Powell L.H., Sutton-Tyrrell K., Meyer P.M. Sleep difficulty in women at midlife: a community survey of sleep and the menopausal transition. Menopause. 2003;10(1):19–28. https://doi.org/10.1097/00042192-200310010-00005.; Hysing M., Pallesen S., Stormark K.M., Lundervold A.J., Sivertsen B. Sleep patterns and insomnia among adolescents: a population-based study. J Sleep Res. 2013;22(5):549–556. https://doi.org/10.1111/jsr.12055.; Johnson E.O., Roth T., Schultz L., Breslau N. Epidemiology of DSM-IV insomnia in adolescence: lifetime prevalence, chronicity, and an emergent gender difference. Pediatrics. 2006;117(2):e247–256. https://doi.org/10.1542/peds.2004-2629.; Zhang J., Chan N.Y., Lam S.P., Li S.X., Liu Y., Chan J.W. et al. Emergence of Sex Differences in Insomnia Symptoms in Adolescents: A Large-Scale School-Based Study. Sleep. 2016;39(8):1563–1570. https://doi.org/10.5665/sleep.6022.; Lee S.Y., Wuertz C., Rogers R., Chen Y.P. Stress and sleep disturbances in female college students. Am J Health Behav. 2013;37(6):851–858. https://doi.org/10.5993/AJHB.37.6.14.; Coren S. The prevalence of self-reported sleep disturbances in young adults. Int J Neurosci. 1994;79(1-2):67–73. https://doi.org/10.3109/00207459408986068.; Lee S.Y., Vasireddi M., Chen Y.P., Wang Y.T., Hilliard J. PNI Biomarkers and Health Outcomes in College Women. Healthcare (Basel). 2014;2(2):207–219. https://doi.org/10.3390/healthcare2020207.; Xing X., Xue P., Li S.X., Zhou J., Tang X. Sleep disturbance is associated with an increased risk of menstrual problems in female Chinese university students. Sleep Breath. 2020;24(4):1719–1727. https://doi.org/10.1007/s11325-020-02105-1.; Sedov I.D., Cameron E.E., Madigan S., Tomfohr-Madsen L.M. Sleep quality during pregnancy: A meta-analysis. Sleep Med Rev. 2018;38:168–176. https://doi.org/10.1016/j.smrv.2017.06.005.; Kim K.T., Cho Y.W., Bae J.G. Quality of sleep and quality of life measured monthly in pregnant women in South Korea. Sleep Breath. 2020;24(3):1219–1222. https://doi.org/10.1007/s11325-020-02041-0.; Ko Y.L., Lin P.C., Chen S.C. Stress, sleep quality and unplanned Caesarean section in pregnant women. Int J Nurs Pract. 2015;21(5):454–461. https://doi.org/10.1111/ijn.12267.; Tan L., Zou J., Zhang Y., Yang Q., Shi H. A Longitudinal Study of Physical Activity to Improve Sleep Quality During Pregnancy. Nat Sci Sleep. 2020;12:431–442. https://doi.org/10.2147/NSS.S253213.; Lee H., Kim K.E., Kim M.Y., Park C.G. Cluster Analysis of the Combined Association of Sleep and Physical Activity with Healthy Behavior and Psychological Health in Pregnant Women. Int J Environ Res Public Health. 2021;18(4):2185. https://doi.org/10.3390/ijerph18042185.; Yang Y., Li W., Ma T.J., Zhang L., Hall B.J., Ungvari G.S., Xiang Y.T. Prevalence of Poor Sleep Quality in Perinatal and Postnatal Women: A Comprehensive Meta-Analysis of Observational Studies. Front Psychiatry. 2020;11:161. https://doi.org/10.3389/fpsyt.2020.00161.; Attarian H., Hachul H., Guttuso T., Phillips B. Treatment of chronic insomnia disorder in menopause: evaluation of literature. Menopause. 2015;22(6):674–684. https://doi.org/10.1097/GME.0000000000000348.; Lee J., Han Y., Cho H.H., Kim M.R. Sleep Disorders and Menopause. J Menopausal Med. 2019;25(2):83–87. https://doi.org/10.6118/jmm.19192.; Xu Q., Lang C.P. Examining the relationship between subjective sleep disturbance and menopause: a systematic review and meta-analysis. Menopause. 2014;21(12):1301–1318. https://doi.org/10.1097/GME.0000000000000240.; Kravitz H.M., Zhao X., Bromberger J.T., Gold E.B., Hall M.H., Matthews K.A., Sowers M.R. Sleep disturbance during the menopausal transition in a multiethnic community sample of women. Sleep. 2008;31(7):979–990. https://doi.org/10.5665/sleep/31.7.979.; Tom S.E., Kuh D., Guralnik J.M., Mishra G.D. Self-reported sleep difficulty during the menopausal transition: results from a prospective cohort study. Menopause. 2010;17(6):1128–1135. https://doi.org/10.1097/gme.0b013e3181dd55b0.; Kuh D.L., Hardy R., Wadsworth M. Women’s health in midlife: the influence of the menopause, social factors and health in earlier life. Br J Obstet Gynaecol. 1997;104(12):1419. https://doi.org/10.1111/j.1471-0528.1997.tb11016.x.; Gregory A.M., Sadeh A. Sleep, emotional and behavioral difficulties in children and adolescents. Sleep Med Rev. 2012;16(2):129–136. https://doi.org/10.1016/j.smrv.2011.03.007.; Jaussent I., Dauvilliers Y., Ancelin M.L., Dartigues J.F., Tavernier B., Touchon J. et al. Insomnia symptoms in older adults: associated factors and gender differences. Am J Geriatr Psychiatry. 2011;19(1):88–97. https://doi.org/10.1097/JGP.0b013e3181e049b6.; Liu Y., Croft J.B., Wheaton A.G., Perry G.S., Chapman D.P., Strine T.W. et al. Association between perceived insufficient sleep, frequent mental distress, obesity and chronic diseases among US adults, 2009 behavioral risk factor surveillance system. BMC Public Health. 2013;13:84. https://doi.org/10.1186/1471-2458-13-84.; Maski K., Owens J.A. Insomnia, parasomnias, and narcolepsy in children: clinical features, diagnosis, and management. Lancet Neurol. 2016;15(11):1170–1181. https://doi.org/10.1016/S1474-4422(16)30204-6.; Kansagra S. Sleep Disorders in Adolescents. Pediatrics. 2020;145(Suppl. 2): S204–S209. https://doi.org/10.1542/peds.2019-2056I.; Barclay N.L., Gehrman P.R., Gregory A.M., Eaves L.J., Silberg J.L. The heritability of insomnia progression during childhood/adolescence: results from a longitudinal twin study. Sleep. 2015;38(1):109–118. https://doi.org/10.5665/sleep.4334.; Combs D., Goodwin J.L., Quan S.F., Morgan W.J., Shetty S., Parthasarathy S. Insomnia, Health-Related Quality of Life and Health Outcomes in Children: A Seven Year Longitudinal Cohort. Sci Rep. 2016;6:27921. https://doi.org/10.1038/srep27921.; De Zambotti M., Goldstone A., Colrain I.M., Baker F.C. Insomnia disorder in adolescence: Diagnosis, impact, and treatment. Sleep Med Rev. 2018;39:12–24. https://doi.org/10.1016/j.smrv.2017.06.009.; Taylor D.J., Bramoweth A.D., Grieser E.A., Tatum J.I., Roane B.M. Epidemiology of insomnia in college students: relationship with mental health, quality of life, and substance use difficulties. Behav Ther. 2013;44(3):339–348. https://doi.org/10.1016/j.beth.2012.12.001.; Gaultney J.F. The prevalence of sleep disorders in college students: impact on academic performance. J Am Coll Health. 2010;59(2):91–97. https://doi.org/10.1080/07448481.2010.483708.; Alqudah M., Balousha S.A.M., Al-Shboul O., Al-Dwairi A., Alfaqih M.A., Alzoubi K.H. Insomnia among Medical and Paramedical Students in Jordan: Impact on Academic Performance. Biomed Res Int. 2019:7136906. https://doi.org/10.1155/2019/7136906.; Jiang X.L., Zheng X.Y., Yang J., Ye C.P., Chen Y.Y., Zhang Z.G., Xiao Z.J. A systematic review of studies on the prevalence of insomnia in university students. Public Health. 2015;129(12):1579–1584. https://doi.org/10.1016/j.puhe.2015.07.030.; Carrión-Pantoja S., Prados G., Chouchou F., Holguín M., Mendoza-Vinces Á., Expósito-Ruiz M., Fernández-Puerta L. Insomnia Symptoms, Sleep Hygiene, Mental Health, and Academic Performance in Spanish University Students: A Cross-Sectional Study. J Clin Med. 2022;11(7):1989. https://doi.org/10.3390/jcm11071989.; Carskadon M.A., Acebo C., Jenni O.G. Regulation of adolescent sleep: implications for behavior. Ann N Y Acad Sci. 2004;1021:276–291. https://doi.org/10.1196/annals.1308.032.; Morin C.M., Benca R. Chronic insomnia. Lancet. 2012;379(9821):1129–1141. https://doi.org/10.1016/S0140-6736(11)60750-2.; Shochat T., Loredo J., Ancoli-Israel S. Sleep Disorders in the Elderly. Curr Treat Options Neurol. 2001;3(1):19–36. https://doi.org/10.1007/s11940-001-0021-x.; Foley D.J., Monjan A.A., Brown S.L., Simonsick E.M., Wallace R.B., Blazer D.G. Sleep complaints among elderly persons: an epidemiologic study of three communities. Sleep. 1995;18(6):425–432. https://doi.org/10.1093/ sleep/18.6.425.; Hirshkowitz M., Whiton K., Albert S.M., Alessi C., Bruni O., DonCarlos L. et al. National Sleep Foundation’s sleep time duration recommendations: methodology and results summary. Sleep Health. 2015;1(1):40–43. https://doi.org/10.1016/j.sleh.2014.12.010.; Blay S.L., Andreoli S.B., Gastal F.L. Prevalence of self-reported sleep disturbance among older adults and the association of disturbed sleep with service demand and medical conditions. Int Psychogeriatr. 2008;20(3):582–595. https://doi.org/10.1017/S1041610207006308.; Leblanc M.F., Desjardins S., Desgagné A. Sleep problems in anxious and depressive older adults. Psychol Res Behav Manag. 2015;8:161–169. https://doi.org/10.2147/PRBM.S80642.; Montgomery P. Treatments for sleep problems in elderly people. BMJ. 2002;325(7372):1049. https://doi.org/10.1136/bmj.325.7372.1049.; Brewster G.S., Riegel B., Gehrman P.R. Insomnia in the Older Adult. Sleep Med Clin. 2018;13(1):13–19. https://doi.org/10.1016/j.jsmc.2017.09.002.; Porwal A., Yadav Y.C., Pathak K., Yadav R. An Update on Assessment, Therapeutic Management, and Patents on Insomnia. Biomed Res Int. 2021:6068952. https://doi.org/10.1155/2021/6068952.; Sateia M.J., Buysse D.J., Krystal A.D., Neubauer D.N., Heald J.L. Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline. J Clin Sleep Med. 2017;13(2):307–349. https://doi.org/10.5664/jcsm.6470.; Riemann D., Baglioni C., Bassetti C., Bjorvatn B., Dolenc Groselj L., Ellis J.G. et al. European guideline for the diagnosis and treatment of insomnia. J Sleep Res. 2017;26(6):675–700. https://doi.org/10.1111/jsr.12594.; Ellis J.G., Cushing T., Germain A. Treating Acute Insomnia: A Randomized Controlled Trial of a “Single-Shot” of Cognitive Behavioral Therapy for Insomnia. Sleep. 2015;38(6):971–978. https://doi.org/10.5665/sleep.4752.; Lie J.D., Tu K.N., Shen D.D., Wong B.M. Pharmacological Treatment of Insomnia. P T. 2015;40(11):759–771. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634348/.; Del Pinto R., Grassi G., Ferri C., Pengo M.F., Lombardi C., Pucci G. et al. Diagnostic and Therapeutic Approach to Sleep Disorders, High Blood Pressure and Cardiovascular Diseases: A Consensus Document by the Italian Society of Hypertension (SIIA). High Blood Press Cardiovasc Prev. 2021;28(2):85–102. https://doi.org/10.1007/s40292-021-00436-y.; Auld F., Maschauer E.L., Morrison I., Skene D.J., Riha R.L. Evidence for the efficacy of melatonin in the treatment of primary adult sleep disorders. Sleep Med Rev. 2017;34:10–22. https://doi.org/10.1016/j.smrv.2016.06.005.; Culpepper L., Wingertzahn M.A. Over-the-Counter Agents for the Treatment of Occasional Disturbed Sleep or Transient Insomnia: A Systematic Review of Efficacy and Safety. Prim Care Companion CNS Disord. 2015;17(6):10.4088/PCC.15r01798. https://doi.org/10.4088/PCC.15r01798.; Lemoine P., Nir T., Laudon M., Zisapel N. Prolonged-release melatonin improves sleep quality and morning alertness in insomnia patients aged 55 years and older and has no withdrawal effects. J Sleep Res. 2007;16(4):372–380. https://doi.org/10.1111/j.1365-2869.2007.00613.x.; Wade A.G., Ford I., Crawford G., McMahon A.D., Nir T., Laudon M., Zisapel N. Efficacy of prolonged release melatonin in insomnia patients aged 55–80 years: quality of sleep and next-day alertness outcomes. Curr Med Res Opin. 2007;23(10):2597–2605. https://doi.org/10.1185/030079907X233098.; Garzón C., Guerrero J.M., Aramburu O., Guzmán T. Effect of melatonin administration on sleep, behavioral disorders and hypnotic drug discontinuation in the elderly: a randomized, double-blind, placebo-controlled study. Aging Clin Exp Res. 2009;21(1):38–42. https://doi.org/10.1007/BF03324897.; Luthringer R., Muzet M., Zisapel N., Staner L. The effect of prolongedrelease melatonin on sleep measures and psychomotor performance in elderly patients with insomnia. Int Clin Psychopharmacol. 2009;24(5):239–249. https://doi.org/10.1097/YIC.0b013e32832e9b08.; Wade A.G., Ford I., Crawford G., McConnachie A., Nir T., Laudon M., Zisapel N. Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety. BMC Med. 2010;8:51. https://doi.org/10.1186/1741-7015-8-51.; Sanchez-Barcelo E.J., Rueda N., Mediavilla M.D., Martinez-Cue C., Reiter R.J. Clinical Uses of Melatonin in Neurological Diseases and Mental and Behavioural Disorders. Curr Med Chem. 2017;24(35):3851–3878. https://doi.org/10.2174/0929867324666170718105557.; Brzezinski A., Vangel M.G., Wurtman R.J., Norrie G., Zhdanova I., Ben-Shushan A., Ford I. Effects of exogenous melatonin on sleep: a meta-analysis. Sleep Med Rev. 2005;9(1):41–50. https://doi.org/10.1016/j.smrv.2004.06.004.; Jaiswal S.J., McCarthy T.J., Wineinger N.E., Kang D.Y., Song J., Garcia S. et al. Melatonin and Sleep in Preventing Hospitalized Delirium: A Randomized Clinical Trial. Am J Med. 2018;131(9):1110–1117.e4. https://doi.org/10.1016/j.amjmed.2018.04.009.; https://www.med-sovet.pro/jour/article/view/7211